200913976 九、發明說明 【發明所屬之技術領域】 本發明係關於藉由裝塡於遺體的口、鼻、耳、肛門、 女性的陰道等之體腔而封閉，用以防止體液自遺體漏出之 凝膠狀之體液漏出防止劑、將其注入遺體的體腔所使用之 注入器及插入管，以及使用此等之遺體處理裝置。 【先前技術】 一般而言’人類或動物於死亡後體腔各部份的肌肉弛 緩，胃液、肺液、腹水、排泄物等之體液多會漏出，成爲 惡臭、或因病原菌感染之原因。因此，例如於醫院，於確 認死亡後，於遺體的口、鼻、耳、肛門、女性的陰道等之 體腔’進行裝塡大量的紗布、脫脂棉等，防止體液漏出， 另外，對於事故或手術後之遺體開口部份亦採取相同處理 。然而’裝塡紗布、脫脂棉等於體腔之作業，大多係藉由 從業者或護士等之手進行，該作業的煩雜或不衛生，同時 因爲紗布、脫脂棉等之吸水能力低，而有於作業中或作業 後經常漏出體液之問題，或亦有從事作業中因該漏出物質 而死後感染之可能性，強烈要求該解決方法。 因此，已知取代紗布、脫脂棉等，裝塡高吸水性樹脂 粉末於口、鼻、耳、咽喉等，已知例如使用注射器，裝塡 高吸水性樹脂粉末於口、鼻、耳之方法（參考特開平1 0 -29 8 0 01號公報）、將含安定化二氧化氯之吸水性樹脂粉末 ，直接使用粉末於咽喉，以水溶性薄片包住使用於耳孔、 -4- 200913976 鼻孔之方法（參考特開平7-2653 67號公報）等。然而，即使 裝塡如此高吸水性樹脂粉末，因爲流動性差，裝塡於狹窄 的體腔，例如咽喉部份、肛門等係困難的。另外，僅爲鼻 孔或耳孔之入口部份時，可以如注射器之注入器充塡如此 的微細粉末，但不能充塡至深處。另外，爲充塡至深處， 注射器必須一邊動一邊充塡時，由先端出來的微細粉末飛 散，反而污染遺體周圍。 爲解決如此高吸水性樹脂粉末之充塡性或作業性差、 或飛散等之問題，近年來提出使用凝膠而非粉體，已知例 如使用以適量的水溶解加入除臭劑之粉末聚合物，適當混 合而成凝膠狀物之方法（參考特開平8- 1 3 3 90 1號公報）、或 使用以二甲基丙烯醯胺爲主要成份之兩性凝膠之方法（參 考特開2001-288002號公報）、使用於以醇爲主要成份之凝 膠中，分散許多高吸水性聚合物粉體之方法（參考特許第 3 5 8 6207號公報）。 關於充塡如此之凝膠狀體液漏出防止劑於例如鼻孔深 處之咽喉部份時之充塡方法，參考圖1下說明時，如特許 第3 5 862 07號公報記載，收納凝膠狀體液漏出防止劑2於注 入器1係具備由後端處自在滑動地插入之活塞3以及該先端 被覆保護蓋5之注入口 4，以薄膜包裝（未圖示）包住之密封 狀態。插入咽喉部份B等體腔之插入管6係一端具有連接 注入器1之注入口 4之連接部份7，另一端具有插入鼻孔A 之開口部份8。 接著，說明使用如此準備之遺體處理裝置之方法。圖 -5- 200913976 1中，A係鼻孔、B係咽喉部份、c係舌、D係氣管、E係 食道。使用時，自薄膜包裝取出注入器1，卸下注入器1之 注入口 4之保護蓋5，嵌入插入管6之連接部份7於注入口 4 ，連接插入管6。接著，將插入管6之開口部份8自鼻孔A 朝向咽喉部份B插入，當插入管6之制止部份9碰到鼻尖B 時，停止插入。接著，推壓插入器1之活塞3，使注入器1 內之凝膠狀體液漏出防止劑2經由插入管6，注入咽喉部份 B。壓出注入器1內之凝膠狀體液漏出防止劑2，充塡後， 自鼻孔A除去注入器1及插入管6。 如上述之凝膠狀體液漏出防止劑係具有流動性高，即 使鼻孔、耳孔等之狹窄體腔，仍容易充塡，即使以注入器 壓入並不飛散之優點。尤其，使分散許多高吸水性聚合物 粉體之凝膠時，吸水性能高，此聚合物吸收自體腔漏出的 體液，將可防止漏出於外部。然而，因爲傳統之凝膠狀體 液漏出防止劑係以注入器具注入、裝塡於體腔後之吸液速 度慢，因此，有因死後體腔各部份之肌肉弛緩而體液容易 漏出之問題。另外，就剛注入、裝塡於體腔後之吸液能力 上亦稱不上足夠。另外，組合傳統之注入器及插入管時， 該操作性有問題，並且因爲於細長插入管之中間部份有表 示插入停止位置之標記或制止部份，所以有需要對插入管 的插入熟練，難以經常於一定施用部位，確實地注入、裝 塡體液漏出防止劑之問題。 【發明內容】 -6 - 200913976 發明之揭示 發明所欲解決之課題 因此’本發明之基本目的係提供以注入器具注入、裝 塡於遺體體腔’於體腔內與體液接觸時，迅速地吸收體液 ，膨潤而凝固，可有效地防止體液漏出之遺體的體液漏出 防止劑。 本發明另外的目的係提供可作業性佳地注入、裝塡如 此之體液漏出防止劑於遺體體腔，簡便地、確實地且衛生 地進行遺體體腔之封閉作業，可有效地且確實地防止體液 漏出之遺體處理裝置。 本發明之其他目的係提供操作性優異，不需要對插入 管之插入熟練，可確實地於經常一定施用部位，作業性佳 地注入、裝塡體液漏出防止劑之遺體的體液漏出防止劑注 入用插入管及使用其之遺體處理裝置。 課題之解決手段 爲達成上述目的，由本發明提供於含有選自聚乙二醇 及非離子性界面活性劑所成群之與水混合時發熱之液狀基 材（A)、及至少1種選自聚環氧化物系之熱可塑性非離子型 吸水性樹脂、丙烯酸聚合物之羧乙烯基聚合物、丙烯酸聚 合物之羧乙烯基聚合物之鹼鹽、親油性蒙脫石、合成鋰蒙 脫石、天然鋰蒙脫石、及膨潤土所成群之分散安定劑（B) 之黏稠液基劑中，分散高吸水性樹脂粉末（C)爲特徵之遺 體的體液漏出防止劑。 200913976 於適合的型態，上述分散安定劑（B)係聚環氧化物系 之熱可塑性非離子型吸水性樹脂。另外，本發明之體液漏 出防止劑，可更含有可溶於水之醇系有機溶劑（D)及增黏 劑（E)中之任一種或兩者，亦可再含有至少1種選自殺菌劑 、防黴·防腐劑、除臭劑及香料所成群。 另外’依據本發明，提供具備於先端具有吐出口部份 或吐出筒部份，及於後端部份具有鈎住手指用之突出於半 徑方向外側之凸緣部份，內部收納體液漏出防止劑用之筒 狀本體’以及具有自後端部份側自在地滑動地插入於該筒 狀本體內之活塞之注入器爲特徵之遺體的處理裝置。 於適當之型態，上述注入器之筒狀本體係於先端具有 吐出口部份或吐出筒部份之圓筒狀構件，及被覆該外圍之 覆蓋構件而成，上述活塞係自在地滑動地插入於上述圓筒 狀構件。 依據本發明之更具體型態，提供自遺體鼻孔插入，注 入、裝塡體液漏出防止劑於咽喉部份用之處理裝置，具備 具有可撓性之合成樹脂製插入管；及於先端具有連接上述 插入管用之吐出筒部份，以及於後端部份具有鈎住手指用 之突出於半徑方向外側之凸緣部份之筒狀本體，以及具有 自後端部份側自在地滑動地插入於該筒狀本體內之活塞之 注入器’於上述筒狀本體內部收納體液漏出防止劑爲特徵 之遺體處理裝置。 於適當之型態，上述注入器之筒狀本體係於先端具有 吐出筒部份之圓筒狀構件，及被覆該外圍之覆蓋構件而成 -8- 200913976 ’上述凸緣部份係設置於上述覆蓋構件。上述插入管係該 先端開口之通常之插入管或亦可爲先端部份附近的側壁具 有1個以上之開孔部份之插入管，但以該先端部份係形成 約半球狀’而且於該側面具有開孔部份，以及於後端部份 具有用以連接上述注入器之吐出筒部份之連接部份。其他 之適合型態中，上述插入管的先端部份係藉由向著半徑方 向中心，向外側彎曲延伸之多數舌片，形成約半球狀，及 由該多數舌片之先端所形成之開口與舌片間空隙而成之開 口部份所形成，於後端部份具有用以連接上述注入器之吐 出筒部份之連接部份。 即使上述任一種型態，上述插入管係以具有自該後端 所定距離之位置，具有突出於半徑方向外側之制止部份爲 宜。另外，上述插入管係以具有自先端所定距離之位置， 具有彎曲部份爲宜。 本發明之更具體之其他型態，爲注入·裝塡體液漏出 防止劑於遺體之肛門及/或陰道用之處理裝置，具備於先 端具有吐出口部份，及於後端部份具有鈎住手指用之突出 於半徑方向外側之凸緣部份之筒狀本體，以及具有自後端 部份側自在地滑動地插入於該筒狀本體內之活塞之注入器 ’於上述筒狀本體內部收納體液漏出防止劑爲特徵之遺體 處理裝置。此處理裝置時，作爲體液漏出防止劑，可使用 如上述之含有高吸水性樹脂粉末之凝膠狀之體液漏出防止 劑、高吸水性樹脂粉末或將其壓縮整形者、或將高吸水性 樹脂粉末與纖維等之充塡材料一同壓縮整形者、或單獨或 -9 - 200913976 組合吸水性纖維狀充塡材料等。於上述筒狀本體的內部， 自吐出口部份側依序收納含高吸水性樹脂粉末之壓縮整形 體或凝膠狀之體液漏出防止劑，及纖維狀充塡材料，尤其 吸水性纖維狀充塡材料爲宜。 關於適當之型態’於上述筒狀本體先端之吐出口部份 係藉由向著半徑方向中心，向外側彎曲延伸之多數舌片， 形成約半球狀，及由該多數舌片之先端所形成之開口與舌 片間空隙而成之開口部份所形成。另外，於上述筒狀本體 之先端’冠上可覆蓋該吐出口部份之裝卸自由之保護蓋爲 宜。 關於適當之型態，於上述筒狀本體之約中間部份，具 有突出於半徑方向外側之制止部份。更適宜的係上述筒狀 本體係於先端具有吐出口部份之圓筒狀構件，及被覆該外 圍之覆蓋構件而成，於上述圓筒狀構件之後端部份設有上 述凸緣部份，於上述覆蓋構件之所定位置設有上述制止部 份，並且，該活塞係自在地滑動地插入於上述圓筒狀構件 內。 根據本發明之其他方面，提供爲可撓性之合成樹脂製 插入管，先端部份形成約半球狀而封閉，並且於該側面， 具有多數開孔部份之插入管本體，及於該插入管本體之後 端部份所設置之具有用以連接體液漏出防止劑之注入器之 吐出筒部份之連接部份，於該連接部份之所定位置具有突 出於半徑方向外側之制止部份爲特徵之遺體的體液漏出防 止劑注入用插入管。 -10- 200913976 根據具體的其他型態，提供爲可撓性之合成樹脂製插 入管，插入管的先端部份係藉由向著半徑方向中心，向外 側彎曲延伸之多數舌片，形成約半球狀，及由該多數舌片 之先端所形成之開口與舌片間空隙而成之開口部份所形成 之插入管本體，及於該插入管本體之後端部份所設置之具 有用以連接體液漏出防止劑之注入器之吐出筒部份之連接 部份，於該連接部份之所定位置具有突出於半徑方向外側 之制止部份爲特徵之體液漏出防止劑注入用插入管。 關於上述任一種型態之插入管，上述插入管本體係以 距離自先端所定距離之位置，具有彎曲部份爲宜。 另外，依據本發明，亦提供作爲套裝組之遺體處理裝 置。一個處理裝置係以具備上述處理裝置、及上述遺體的 體液漏出防止劑注入用插入管爲特徵。 其他的遺體處理裝置係具備上述之自鼻孔插入，注入 、裝塡體液漏出防止劑於咽喉部份用之處理裝置，及上述 之注入·裝塡體液漏出防止劑於肛門及/或陰道用之處理 裝置，及防止自耳孔及/或鼻孔漏出體液用之纖維製封閉 材料爲特徵。作爲此套裝組之遺體處理裝置亦以更具備口 中裝塡用之纖維製封閉材料尤佳。 發明之功效 因爲本發明之遺體的體液漏出防止劑係含有選自聚乙 二醇及非離子性界面活性劑所成群之與水混合時發熱之液 狀基材（A)、及至少1種選自聚環氧化物系之熱可塑性非離 -11 - 200913976 子型吸水性樹脂、羧乙烯基聚合物、羧乙烯基聚合物之鹼 鹽、親油性蒙脫石、合成鋰蒙脫石、天然鋰蒙脫石、及膨 潤土所成群之分散安定劑（B)之黏稠液基劑中，分散高吸 水性樹脂粉末（C)之凝膠狀物，所以以注入器具注入、裝 塡於遺體之體腔，於體腔內與體液接觸時，因上述液狀基 材（A)之發熱作用，提高上述高吸水性樹脂粉末（C)之吸液 速度，迅速地吸收體液、膨潤而凝固成無流動性之固態凝 膠狀（固體狀凝膠），藉此可有效地進行防止體液漏出。 另外，依據本發明之體液漏出防止劑之適合型態，因 爲上述分散安定劑（B)係聚環氧化物系之熱可塑性非離子 型吸水性樹脂，所以可更確實地維持與體液接觸時之上述 高吸水性樹脂粉末（C)之均勻分散狀態。因此，含有聚環 氧化物系之熱可塑性非離子型吸水性樹脂作爲分散安定劑 之體液漏出防止劑，於注入、裝塡於遺體之體腔時，整體 迅速地吸收體液、膨潤而凝固成無流動性之固態凝膠狀， 可更有效地進行防止體液漏出。另外，本發明之體液漏出 防止劑，藉由更含有作爲助溶劑之可溶於水之醇系有機溶 劑（D)及提高流動性用之增黏劑（E)中之任一種或二者，將 容易調整黏度，可提高壓出流動性，將可更順利地注入、 裝塡於咽喉部份等之狹窄體腔。另外，藉由含有至少1種 選自殺菌劑、防黴·防腐劑、除臭劑及香料所成群，亦可 合倂發揮此等所需效果。 另外’本發明之遺體處理裝置係具備於先端具有吐出 口部份’及於後端部份具有鈎住手指用之突出於半徑方向 -12- 200913976 外側之凸緣部份之筒狀本體，以及具有自後端部份側自在 地滑動地插入於該筒狀本體內之活塞之注入器，因爲於上 述筒狀本體內部收納上述體液漏出防止劑，所以注入·裝 塡體液漏出防止劑於遺體體腔時，發揮上述之功效，並且 因爲於筒狀本體之後端部份具有鈎住手指用之凸緣部份， 所以可更簡易地作業性佳地進行對遺體體腔之體液漏出防 止劑之注入操作。 關於適當之型態係上述注入器之筒狀本體係於先端具 有吐出口部份或吐出筒部份之圓筒狀構件，及被覆該外圍 之覆蓋構件而形成，因爲上述凸緣部份係設置於上述圓筒 狀構件或覆蓋構件，所以與一體成形時相比，可以低成本 且容易地製造筒狀本體，藉由使覆蓋構件成爲斷面多角形 之外形，或使覆蓋構件著色，或著色使該顏色與其他構件 顏色相異，形成彩色的注入器，於醫院中護士可容易判別 而不會錯認爲一般注射器，或又可明顯地把握施用場所。 另外，關於自鼻孔插入，注入、裝塡上述體液漏出防 止劑於咽喉部份用之處理裝置之適合型態，因爲具有可撓 性之合成樹脂製插入管之先端部份形成約半球狀，而且於 該側面具有開孔部份，所以自鼻孔至咽喉部份，可順利地 插入插入管，並且，無如僅先端具有開口之插入管，先端 開口接觸施用部位時受阻塞而難以注入體液漏出防止劑之 問題，可順利地注入、裝塡體液漏出防止劑。 另一方面，依據插入管之其他適合型態，因爲可撓性 之合成樹脂製插入管本體之先端部份，藉由向著半徑方向 -13- 200913976 中心，向外側彎曲延伸之多數舌片，形成約半球狀，及由 該多數舌片之先端所形成之開口與舌片間空隙而成之開口 部份所形成，由活塞壓出注入器中所充塡之體液漏出防止 劑時，體液漏出防止劑撐開多數舌片而壓出，並且，因爲 自擴張開的舌片間之間隙亦壓出，所以該表面積變大。因 此，與體腔內之體液接觸時，將迅速吸液而成無流動性之 固態凝膠，將可更有效地迅速地防止體液漏出。 另外，自插入管後端之所定距離之位置，以用以連接 注入器之吐出筒部份之連接部份之所定位置爲宜，因爲具 有突出於半徑方向外側之制止部份，與細長之插入管之中 間部份設置制止部份時相比，可縮短插入管長度，不需對 插入插入管熟練而可順利地進行，而且，開孔部位可確實 地就位於經常一定施用部位，注入、裝塡體液漏出防止劑 〇 進而’依據插入管之適合型態，因爲上述插入管本體 係距離自先端所定距離之位置，具有彎曲部份，所以自鼻 孔插入咽頭部份深處時，可無阻力順利地插入插入管。 另一方面’關於注入裝塡上述體液漏出防止劑於遺 體之肛門及/或陰道用之處理裝置，因爲於注入器之筒狀 本體的內部，自吐出口部份側依序收納含高吸水性樹脂粉 末之壓縮整形體或凝膠狀之體液漏出防止劑，及纖維狀充 塡材料’尤其吸水性纖維狀充塡材料爲宜，此等注入於體 腔內時’吸收體液及污物中液體之體液漏出防止劑中之高 吸水性樹脂粉末膨脹，並且，因爲其部份滲透於纖維狀充 -14- 200913976 塡材料，成爲固體狀凝膠，所以可確實地防止體液及污物 漏出。 另外，於上述筒狀本體之先端，冠上可覆蓋上述吐出 口部份之裝卸自由之保護蓋時’不必取下保護蓋，可直接 一起注入·裝塡體液漏出防止劑及纖維狀充塡材料。因此 ，可作業性佳，簡易地且衛生地進行遺體之肛門或陰道之 封閉作業。 關於適當的型態，因爲上述筒狀本體先端之吐出口部 份係藉由向著半徑方向中心，向外側彎曲延伸之多數舌片 ，形成約半球狀，及由該多數舌片之先端所形成之開口與 舌片間空隙而成之開口部份所形成，可順利地插入肛門及 /或陰道，並且由活塞壓出所充塡之體液漏出防止劑時， 體液漏出防止劑撐開多數舌片而壓出，並且，因爲自擴張 開的舌片間之間隙亦壓出，所以該表面積變大。因此，與 體腔內之體液接觸時’將迅速吸液而成無流動性之固態凝 膠’將可更有效地迅速地防止體液漏出。另外，因爲於筒 狀本體之約中間部份’具有突出於半徑方向外側之制止部 份，所以不需要熟練地插入’插入管之開口部份或注入器 之吐出口部位可確實地就位於經常一定施用部位，注入、 裝塡體液漏出防止劑及纖維狀充塡材料。 進而’作爲本發明之套裝組之遺體處理裝置，因爲具 備自上述鼻孔插入’注入、裝塡體液漏出防止劑於咽喉部 份用之處理裝置，及注入.裝塡體液漏出防止劑於肛門及 /或陰道用之處理裝置’及防止自耳孔及/或鼻孔漏出體液 -15- 200913976 用之纖維製封閉材料，亦以更具備口中裝塡用之纖維製封 閉材料爲宜，可構成容器內具備全部必要的構成處理工具 之遺體處理套裝組，所以攜帶簡單，將可更迅速地進行遺 體處置。另外，藉由亦具備防止自耳孔及/或鼻孔漏出體 液用之纖維製封閉材料或口中裝塡用之纖維製封閉材料， 亦可更確實地防止因死後之體腔各部份之肌肉弛緩而體液 漏出。 用以實施發明之最佳型態 本發明者爲解決上述傳統問題努力硏究的結果係發現 於含有選自聚乙二醇及非離子性界面活性劑所成群之與水 混合時發熱，迅速地可溶於水之液狀基材（A)、及溶解於 其之上述特定之分散安定劑（B)之黏稠液基劑中，分散高 吸水性樹脂粉末（C)而成之凝膠狀體液漏出防止劑係與體 液接觸時之因上述液狀基材（A)之發熱作用，提高上述高 吸水性樹脂粉末（C)之吸液速度，迅速地吸收體液、膨潤 而凝固成無流動性之固態凝膠狀，而達成完成本發明者。 亦即，因爲一般高吸水性樹脂粉末（C)之吸水速度係 溫度愈高而有變高之趨勢，所以藉由與體液接觸時之上述 液狀基材（A)之發熱作用，提高上述高吸水性樹脂粉末（C) 之吸液速度，迅速地吸收體液、膨潤而凝固成無流動性之 固態凝膠狀。然而，因爲吸液速度愈高，所注入之凝膠狀 物與體液接觸之表面部份迅速地凝固成無流動性之固態凝 膠狀，所以高吸水性樹脂粉末（C)之均勻分散性容易崩潰 -16- 200913976 。因此，本發明之體液漏出防止劑中，於黏稠液基劑中進 一步使溶解可吸收各種電解質水溶液，幾乎不受電解質濃 度影響之上述特定之分散安定劑（B)，保持高吸水性樹脂 粉末（C)之均勻分散性者。因此，本發明之體液漏出防止 劑係以注入器具注入·裝塡於遺體之體腔時，全體地且迅 速地吸收體液、膨潤而凝固成無流動性之固態凝膠狀，可 有效地進行防止體液漏出。 本發明使用之作爲與水混合時發熱之於室溫爲液狀之 基材（A)係聚乙二醇（聚合度平均分子量爲600以下）、或非 離子性界面活性劑，可舉例如椰子油脂肪酸單乙醇醯胺、 椰子油脂肪酸二乙醇醯胺1 : 1型、椰子油脂肪酸二乙醇醯 胺1 : 2型、聚環氧乙烷椰子油脂肪酸單乙醇醯胺、月桂酸 二乙醇醯胺、聚環氧乙烷月桂基醚、聚環氧乙烷鯨蠟醚、 聚環氧乙烷高級醇醚、聚環氧乙烷聚環氧丙烷乙二醇（加 成環氧乙烷於聚丙二醇之Pluronic型非離子界面活性劑） 、聚環氧乙烷烷基（烷基之碳原子數爲12〜14個）醚（環氧 乙烷之加成莫耳數：7〜12莫耳）等之聚環氧乙烷烷基醚系 、山梨糖醇酐脂肪酸酯系、聚環氧乙烷山梨糖醇酐脂肪酸 酯系等之界面活性劑，此等可以單獨或組合2種以上使用 。此等之液狀基材（A)中，以液狀之聚乙二醇（聚合度之平 均分子量約爲200〜600)爲宜。 此等之液狀基材（A)中，尤其液狀之聚乙二醇（聚合度 之平均分子量約爲200〜600)係於低溫（約30 °C〜50 °C )可 容易溶解上述之分散安定劑（B)，尤其聚環氧化物系之熱 -17- 200913976 可塑性非離子型吸水性樹脂粉末，另外，與水混合時，如 後述之試驗例1及3所示，接觸水時發熱而水溫上升（上升 1 0 °C〜1 2 °c )，另外，因爲爲界面活性劑，所以與水之相 容性佳，與水容易混合、溶解，如上所述提高高吸水性樹 脂之吸水速度，迅速地凝固成無流動性之固態凝膠狀，可 防止體液漏出。 上述液狀基材（A)之含量係以體液漏出防止劑整體量 之約1 0〜8 5質量％爲宜，以約2 〇〜8 0質量％尤佳’以約3 0 〜70質量％更好。液狀基材（A)之含量係配合大量之超過 8 5質量％時，雖然無高吸水性樹脂粉末分散性之問題，但 因爲難以成爲凝膠狀，液體的狀態近於溶液’所以並不適 宜。另一方面，液狀基材（A)之含量過低時’因爲將難以 形成良好的凝膠狀態，所以不適宜。 本發明之體液漏出防止劑係除了上述液狀基材（A)之 外，於不損及本發明功效之量的比率，因應需要，亦可含 有陰離子性界面活性劑。 作爲陰離子性界面活性劑’可舉例如聚環氧乙烷烷基 醚硫酸鹽系、聚環氧乙烷月桂基醚硫酸鈉、聚環氧乙烷月 桂基醚硫酸三乙醇胺、聚環氧乙烷烷基（烷基之碳數爲11 〜15個）醚硫酸鈉（環氧乙烷之加成莫耳數：3)、烷基（烷基 之碳數爲11、13、15個）三乙醇胺、烷基硫酸鈉、烷基硫 酸三乙醇胺、高級醇硫酸鈉等之烷基醚硫酸系；聚環氧乙 烷烷基磺基琥珀酸二鈉、聚環氧乙烷磺基琥珀酸、聚環氧 乙烷磺基琥珀酸月桂基二鈉、磺酸月桂基二鈉、磺基琥珀 -18- 200913976 酸聚環氧乙烷月桂基乙醇醯胺二鈉等之磺基琥珀酸鹽系； 十二烷基苯磺酸鈉等之烷基苯磺酸系等之界面活性劑，此 等係可以單獨或組合2種以上使用。 本發明使用之分散安定劑（B)係用以使保持高吸水性 樹脂粉末之均勻分散狀態者，可使用至少1種選自可吸收 各種電解質水溶液，幾乎不受電解質濃度影響之聚環氧化 物系之熱可塑性非離子型吸水性樹脂、丙烯酸聚合物之羧 乙烯基聚合物、丙烯酸聚合物之羧乙烯基聚合物之鹼鹽、 親油性蒙脫石、合成鋰蒙脫石、天然鋰蒙脫石、及膨潤土 所成群。此等之分散安定劑（B)中，以聚環氧化物系之熱 可塑性非離子型吸水性樹脂爲宜，此樹脂係可吸收各種電 解質水溶液，幾乎不受電解質濃度影響，可吸收酸或鹼性 水溶液。 分散安定劑（B)之含量係以體液漏出防止劑整體量之 約0.5〜40質量％爲宜，以約1〜30質量％尤佳。分散安定 劑（B)之含量若過低時，將難以保持高吸水性樹脂粉末之 均勻分散性，另一方面’即使配合多量而超過4 0質量％ ’ 亦未見其以上之改善效果’就經濟性上並不適宜。 作爲本發明使用之高吸水性樹脂粉末（C)，可使用傳 統已知之各種高吸水性樹脂之粉末，但並非侷限於特定物 ，可適合使用至少1種選自此等中之聚乙烯丙烯酸酯、聚 丙烯酸鹽、褐藻酸鹽、丙烯酸接枝共聚物交聯物、乙烯醇 與聚丙烯酸之共聚物、聚乙二醇系聚合物、聚丙烯醯胺系 樹脂、聚丙烯酸與馬來酸之共聚物、聚環氧乙烷系聚合物 -19- 200913976 、及聚褐藻酸鹽系聚合物所成群。 上述高吸水性樹脂粉末（C)係以平均粒度約爲1 8〜1 60 網目（依戴勒（Tyler)表示）之粉體爲宜，以約30網目〜140 網目尤佳。 另外，高吸水性樹脂粉末（C)之含量係必須遺體內之 體液不自體腔漏出，立即吸收而膨脹，製成無流動性之凝 膠之必須量。高吸水性樹脂粉末之含量係以體液漏出防止 劑整體量之約5〜50質量％爲宜，以約15〜3 5質量％尤佳。 本發明之體液漏出防止劑係除了上述各成份，因應需 要’亦可含有作爲助溶劑之可溶於水之醇系有機溶劑（D) 、或進而用以使流動性提升之增黏劑（E)。 作爲醇系有機溶劑（D)，可溶於上述液狀基材或極性 溶劑的水之溶劑皆可使用，並無特別限定者，可適合使用 至少1種選自乙二醇、丙二醇、二乙二醇、三乙二醇、甘 油、甲醇、乙醇、及異丙醇所成群之醇系有機溶劑。此等 醇系有機溶劑中，以甘油爲宜。甘油係容易與水混合，雖 僅有少量，但混合時水溫稍上升（約3 t )。因此，可幫助 增加高吸水性樹脂之吸水速度，並且提升所調製體液漏出 防止劑之黏性，使流動性佳，低溫時，幫助防止凝膠的凝 固。 醇系有機溶劑之含量係以體液漏出防止劑整體量之約 3〜5 0質量％爲宜，以約5〜3 0質量％尤佳。 作爲上述增黏劑（E)，並無特別的限定，可適合使用 至少1種選自羧甲基纖維素鈉、羧甲基纖維素、甲基纖維 -20- 200913976 素、聚乙烯醇、聚乙烯吡咯烷酮、sola gum、及褐藻酸鈉 所成群之增黏劑。增黏劑之含量係以體液漏出防止劑整體 量之約0.5〜30質量％爲宜，以約1〜20質量％尤佳。 本發明之體液漏出防止劑係因應需要，可再含有至少 1種選自殺菌劑、防黴·防腐劑、除臭劑、香料等其他添 加劑。 作爲殺菌劑，可舉例如異丙基甲基苯酚、氯胍 (chlorhexidine gluconate)、百里香酚、鄰苯基苯酚、烷基二 甲基苯甲基氯化敍、十六院基氯化紙U定（Cetylpyridinium chloride)、氯化苯乙基銨（Benzethonium chloride)、三氯 沙（Triclosan)、ε-聚賴胺酸、氯化溶菌酶（LySOZyme chloride)、檜木醇、葡萄柚種籽萃取物 '辣椒萃取物r Wasaouro」等，此等係可以單獨或組合2種以上使用。 作爲防黴.防腐劑，可舉例如對羥基苯甲酸鈉、對羥 基苯甲酸丁酯、對羥基苯甲酸丙酯、對羥基苯甲酸異丁酯 、苯甲酸鈉、丙酸鈉、腐絕（Thiabendazole)、異噻哩啉酮 (Isothiazolone)等’此等係可以單獨或組合2種以上使用。 作爲除臭劑，可舉例如孟宗竹萃取物、綠茶萃取物、 長鏈甜菜鹼化合物、柿萃取液之總稱型丹寧爲主要成份之 除臭劑、混合數種植物萃取物之植物系特殊除臭劑等，此 等係可以單獨或組合2種以上使用。 另外’作爲香料’可舉例如花香調、柑橘香調、水果 香S周、木香g周、新鮮（fresh note)調、混合香調、草香調、 薄荷調等之各種天然及人工香料。 -21 - 200913976 如上述之殺菌劑、防黴.防腐劑、除臭劑及香料之含 量’就維持各成份所需效果，得到安全性及良好經濟性之 觀點上’於具有黏性·流動性之體液漏出防止劑整體之所 佔比率’殺菌劑及防黴防腐劑係以分別約爲0 · 0 0 1〜1 5質 量％爲宜’以約0.003〜8質量％尤佳。同樣地，除臭劑係 以約爲0.05〜20質量％爲宜，以約0.1〜10質量％尤佳。另 外，香料係以約爲0.001〜1〇質量％爲宜，以約0.01〜5質 量％尤佳。其他，亦可添加含有色素，該配合量、色調的 選擇等並非特別的限定者，可任意設定。 含有如上述各成份之本發明之體液漏出防止劑之黏度 ，爲具有良好的流動性，以約6,000〜50,OOOcPs爲宜，以 約 10,000〜40,000〇?3尤佳。 另外，在此所謂黏度係使用黏度計（美國Brookfield 社製，「數位黏度計」型式：DV-1 + )，以馬達轉軸 (spindle)No.07，旋轉數：20rpm，使用體液漏出防止劑溫 度：20 °C之測定條件測定之値，但並非侷限於此者，以相 同條件測定之測定値即可。 另外，因爲上述溶劑（A)之含量愈低’因此高吸水性 樹脂粉末（C)之含量愈高，體液漏出防止劑成爲凝膠狀的 時間變短，以及液體的黏度上升，所以可藉由調節此等配 合量，調節成爲因應形成凝膠狀的時間或所需用途（施用 部位）之液黏度。 注入本發明之體液漏出防止劑於體腔之充塡量係因應 施用部位而可適當設定，並非特定限定者。另外’雖依凝 -22- 200913976 膠狀之體液漏出防止劑中所含之高吸水性樹脂之吸水性能 而定’具有凝固3,000ml的水成凝膠狀，防止體液自體腔 內漏出之吸水能力程度即可，一般係以5〜60g爲宜，以 1 0〜40g尤佳。例如自遺體鼻孔注入咽喉部份之體液漏出 防止劑（含5〜50質量％之高吸水性樹脂）之充塡量係以約8 〜40g爲宜，以10〜25g程度尤佳。凝膠狀之體液漏出防 止劑之注入量過多時，因爲注入器具變大，將難以操作， 成本變高。另一方面，注入量過少時，因爲體液難以凝固 成凝膠狀，有體液漏出之危險性，所以不適宜。 【實施方式】 實施例= 以下係參考附圖下，說明關於本發明之遺體處理裝置 之各型態之具體例。 圖2〜圖5係表示自鼻孔插入，注入、裝塡上述體液漏 出防止劑於咽喉部份用之處理裝置，圖2〜圖4係表示該注 入器1 〇，圖5係表示插入管40，符號X係表示收納於注入 器10內之本發明之體液漏出防止劑。 圖2〜圖4係表示注入器10’圖4係表示自圖2所表示的 狀態於中心線周圍旋轉90°狀態之斷面圖。如圖2〜圖4所 示，注入器10係由皆爲高密度聚乙烯、聚酯、聚醯胺等之 塑膠所製作之筒狀本體20及活塞30所構成。筒狀本體20係 由具有於先端作爲吐出口部份運作之吐出筒部份2 2之圓筒 狀構件21，及被覆該外圍之覆蓋構件25所形成。 -23- 200913976 如圖2顯示，覆蓋構件25係斷面成八角形之筒體，係 於醫院中護士可容易判別而不會錯認爲一般注射器之構成 ，並且，先端部份形成前端細之圓錐狀，嵌入圓筒狀構件 21時不易脫落之構成。另外，藉由使覆蓋構件著色，或著 色使該顏色與其他構件顏色相異，形成彩色的注入器，亦 可明顯地掌握施用場所。如圖4明顯顯示，覆蓋構件25係 於該後端部份具有鈎住手指用之突出於半徑方向外側之一 對凸緣部份26。凸緣部份26之先端部份係朝吐出筒部份22 的方向彎曲，手指將容易扣住。進而，於圓筒狀構件21之 後端形成一對凸狀停止部份23,構成爲藉由凸緣部份26與 停止部份23相接觸，手指鈎住凸緣部份26進行注入操作時 ，覆蓋構件25不會往圓筒狀構件2 1後端之後方移動。另外 ，於吐出筒部份22之先端開口部份係冠上於充塡本發明之 體液漏出防止劑於注入器1 0內後可取下之保護蓋2 9。另外 ’於本實施型態中，圓筒狀構件21及覆蓋構件25係分別形 成之個體，但亦可一體成形。另外，圓筒狀構件21及覆蓋 構件2 5係可由黏著劑黏合，或亦可於此等先端部份之接觸 處，將一方構件形成孔部，另一方構件形成嵌合該孔部之 爪部，由此等之關係而互相固定。 另一方面，活塞30係自上述筒狀本體20之圓筒狀構件 2 1之後端部份側自在地滑動地插入。活塞3 0之長度係爲使 可壓出全部內容物之體液漏出防止劑X，設計成比圓筒狀 構件21長度更長。活塞30係具有斷面成十字形之活塞桿31 ，該先端部份係形成直徑比該活塞桿的斷面尺寸稍大之圓 -24- 200913976 形凸緣部份32。自該圓形凸緣部份32突出所形成凸緣部份 33周圍，冠上由合成樹脂或橡膠等所製作之橡膠墊34。於 活塞桿3 1之後端，使手指容易推壓活塞桿3 1，形成接觸手 指之圓板狀部份3 5。活塞3 0係自後端部份側插入筒狀本體 20之圓筒狀構件21時，以上述橡膠墊34接觸注入器10之圓 筒狀構件2 1內周面之狀態，滑動於圓筒狀構件2 1內之構成 。另外，圓筒狀構件2 1之後端部份附近之內周面形成向內 側稍突出之環狀的突出條狀部份24，使活塞桿3 1之圓形凸 緣部份32接觸此突出條狀部份24，使活塞30不易自筒狀本 體2 0拔出之構成。另外，於本實施型態中活塞桿3 1係斷面 成十字形，但亦可爲斷面成圓形等之棒狀。 插入管40係插入鼻孔時，沿著鼻腔形狀，具有可撓柔 軟性之由聚酯彈性體、軟質氯化乙烯樹脂、橡膠等之可撓 性樹脂所製作。如圖5所示，插入管40係由插入管本體40a 及連接部份43而成，插入管本體40a之先端部份41係爲使 容易自鼻孔插入，形成約半球狀而封閉’並且於該側面， 位置錯開之2個地方，具有互相直行方向之各一對開孔部 份42，並且於後端部份，爲連接上述注入器1 〇之吐出筒部 份22，於後側具有稍擴張之圓錐狀之連接部份43。另外’ 於自插入管4 0後端之所定距離（以連接部份4 3之先端位置 爲宜），如圍繞外圍之於半徑方向外側具有突出之斷面成 圓形之制止部份44。制止部份44之直徑必須爲不能插入鼻 孔等所需體腔之尺寸。 上述插入管40之先端部份之開孔部份42係可形成圓形 -25- 200913976 、橢圓形等所需形狀的孔，該位置係以距離插入管先端約 5〜30mm爲宜。另外，開孔部份42之數量於本實施型態 爲4個，但可爲1〜6個程度之任意數。另外，上述制止部 份44係依自插入管本體40a穿過鼻孔插入咽頭部位時之到 達開孔部份42之長度（注入位置）而決定，自插入管40之先 端至制止部份44之長度係以約100〜140mm爲宜，另外， 插入管本體40a係以外徑約爲3.5〜7mm，內徑約爲2〜 5mm爲宜。 另外，上述實施型態中，插入管40之後端部份係與連 接部份43 —體成形，但連接部份43亦可爲分別個體。此時 ，連接部份係以剛性合成樹脂形成爲宜，此連接部份與插 入管本體係由黏合劑、焊接等之適當手段黏合。另外，制 止部份44亦可形成於連接部份之先端，或亦可形成於插入 管之後端。另外，亦可自先端部份之所定位置彎曲插入管 本體，自鼻孔插入至咽頭部位深處時，可無阻力順利地插 入。 使用上述遺體處理裝置時，首先，取下注入器10之吐 出筒部份22之保護蓋29，嵌合吐出筒部份22於插入管40之 連接部份43，連接插入管40及注入器10。接著，自鼻孔 A(參考圖1)朝向咽喉部份B插入插入管本體40a，當插入 管40之制止部份44接觸鼻尖時停止插入。此時，爲減輕插 入阻力，亦可塗佈潤滑劑於插入管本體40a。接著，推壓 注入器10之活塞30 ’使注入器10內之凝膠狀之體液漏出防 止劑X經由插入管40注入咽喉部份B。壓出注入器1 0內之 -26- 200913976 體液漏出防止劑X，充塡後，自鼻孔A拔出注入器1 0及插 入管40。 另外，於上述操作方法中’以連接插入管40於注入器 10之狀態，插入於鼻孔A，但亦可以先插入插入管40於鼻 孔A，接著再連接注入器10於插入管40。另外，注入器10 與插入管40係可以連接狀態收納於容器中，此時可自容器 取出，立即進行處理作業。或者亦可於上述實施型態’注 入器10與插入管40係分開個體，但此等亦可爲製作成一體 者。另外，即使取代插入管40所形成之制止部份44 ’爲記 有標記者，可防止某些程度插入位置的不齊。 接著，關於注入、裝塡體液漏出防止劑於肛門及/或 陰道用之處理裝置之適合實施型態，參考圖6〜圖8下說明 〇 圖6〜圖8係表示注入器10a，圖8係表示自圖6所示的 狀態於中心線周圍旋轉9 0 °狀態之斷面圖。如圖6〜圖8所 示，於此實施型態中，與上述實施型態同樣地，注入器 l〇a係由皆爲高密度聚乙烯、聚酯、聚醯胺等之塑膠所製 作之筒狀本體20a及活塞30所構成。但是與上述實施型態 相異，於注入器1 0a內，纖維狀充塡材料（栓部材料）γ與 凝膠狀之體液漏出防止劑X —起收納。此纖維狀充塡材 料Y係於肛門或陰道之體腔內，凝膠狀之體液漏出防止 劑X成爲固體狀之凝膠後’即使體腔各部份之肌肉死後 弛緩，與固體狀凝膠之間發生空隙，仍可確實地用以達成 防止體液漏出者’但收納物亦可僅爲凝膠狀之體液漏出防 -27- 200913976 止劑X。一個裝置所收納之體液漏出防止劑χ (含5〜5 〇質 量％之高吸水性樹脂）的量約爲1〜10g，以約1〜5g爲宜， 纖維狀充塡材料Y之長度係以設定約爲i 〇〜3 〇mm ,直徑 約爲8〜23mm之範圍內爲宜。 筒狀本體20a係由於先端具有吐出口部份22a之圓筒 狀構件21a，及被覆該外圍之覆蓋構件25a所形成。圓筒 狀構件2 1 a先端之吐出口部份22a係向著半徑方向中心， 向外側彎曲，藉由沿線存在之多數個舌片2 8而形成約半球 狀’以及由該多數舌片2 8之先端部份之開口與舌片間空隙 形成開口部份。各舌片2 8係具有可彎向外側之柔軟性。另 外，死後至僵直間’插入外徑大之筒狀注入器（Syringe)於 肛門或陰道時，因爲肛門管或陰道口張大，至收縮需要時 間’所以成爲體液漏出的原因。另外，圓筒狀構件2 1 a之 外徑細而容易插入’使用簡便。因此，設定圓筒狀構件 2 1 a之外徑約爲1 0〜25mm，以約1 0〜1 5 m m尤佳，內徑約 爲8〜23mm之範圍內爲宜。 覆蓋構件2 5 a係如圖6所示之斷面成八角形之筒體， 係於醫院中護士可容易與一般注射器判別之構成。另外， 藉由使覆蓋構件著色’或著色使該顏色與其他構件顏色相 異，形成彩色的注入器，亦可明顯地掌握施用場所。如圖 8明顯顯示，於上述圓筒狀構件2 1 a之後端部份設置用以 鈎住手指之突出於半徑方向外側之一對凸緣部份2 6，另一 方面，覆蓋構件25a係於該先端部份具有向後方展開之傘 狀制止部份27。自圓筒狀構件2 la之先端至制止部份27之 -28- 200913976 距離係設定於約15〜50mm之範圍內爲宜，制止部份27距 離圓筒狀構件2 1 a之外周面之高度係以設定於容易停止於 肛門或陰道口之約5〜30mm之範圍內爲宜。另外，制止 部份27並不一定如本實施型態之成爲傘狀，只要可確保進 行僅插入注入器1 0於肛門或陰道所定長度之插入位置，不 超過其以上之構件或標記即可，例如可爲圓板狀，或亦可 爲視覺上可容易確認標記。另外，凸緣部份26之先端部份 係係朝吐出筒部份2 2 a的方向彎曲，手指將容易扣住。凸 緣部份26距離圓筒狀構件21a外周面之高度約爲5〜18mm ’先端部份之彎曲程度係以設定於0〜50°之範圍內爲宜。 另外’使用如此覆蓋構件時，上述凸緣部份與制止部份係 可設置於覆蓋構件之所定位置，但以如本實施型態，制止 部份係設置於覆蓋構件之先端部份或覆蓋構件與圓筒狀構 件爲相同長度時，於約略中間部份’凸緣部份係設置於圓 筒狀構件之後端部份爲宜。 另外’圓筒狀構件2 1 a之後端係形成連接於上述—對 凸緣部份2 6 ’突出於側面之一對凸狀停止部份2 3 a，覆蓋 構件2 5 a係構成爲藉由接觸此停止部份2 3 a及凸緣部份2 6 ’手指扣住凸緣部份26進行注入操作時，覆蓋構件25a不 會往圓筒狀構件21a後端之後方移動。另外，於圓筒狀構 件2 1 a之先端部份係冠上於充塡本發明之體液漏出防止劑 於注入器10內後可取下之保護蓋29a。另外，於本實施型 態中’圓筒狀構件2 1 a及覆蓋構件2 5 a係分別形成之個體 ，但亦可一體成形。 -29- 200913976 另一方面，活塞30之構造係與上述實施型態相同，自 後端部份側自在滑動地插入於上述筒狀本體20a之圓筒狀 構件21a。爲使壓出全部內容物之體液漏出防止劑X及纖 維充塡材料Y，活塞3 0之長度係設計成比圓筒狀構件2 1 a 長度更長。活塞30係具有斷面成十字形之活塞桿31，該先 端部份係形成直徑比活塞桿的斷面尺寸稍大之圓形凸緣部 份3 2。自該圓形凸緣部份3 2突出所形成凸緣部份3 3周圍， 冠上由合成樹脂或橡膠等所製作之橡膠墊34。另外，於活 塞桿31之後端，爲使手指容易推壓活塞桿31，形成接觸手 指之圓板狀部份3 5。 活塞30係構成爲自後端部份側插入筒狀主體20之圓筒 狀構件21a時，以上述橡膠墊34接觸注入器10之圓筒狀構 件2 1 a內周面之狀態，滑動於圓筒狀構件2 1 a內。另外， 圓筒狀構件2 1 a之後端部份附近之內周面形成向內側稍突 出之環狀之突出條狀部份24，藉由使活塞桿3 1之圓形凸緣 部份32接觸此突出條狀部份24，構成活塞30不易自筒狀主 體2 0拔出。另外，於本實施型態中活塞桿3 1係斷面成十字 形，但亦可爲斷面成圓形等之棒狀。 使用注入、裝塡上述體液漏出防止劑X及纖維充塡 材料Y於上述肛門及/或陰道用之處理裝置時，首先，不 取下注入器l〇a之吐出口部份22a之保護蓋29a，直接插入 例如肛門或陰道，制止部份27接觸肛門或陰道之外部時停 止插入。此時，爲減輕插入抵抗，亦可塗佈潤滑劑於保護 蓋29a。接著，推壓注入器i〇a之活塞30，與保護蓋29a同 -30- 200913976 時注入注入器1 0a內之凝膠狀體液漏出防止劑X及纖維充 塡材料Y。此時，吸收體液及污物中液體之體液漏出防止 劑X中之高吸水性樹脂粉末膨脹，並且該部份滲透於纖 維充塡材料Y，因爲形成固體狀凝膠，所以可有效地防止 體及污物漏出。之後，自肛門或陰道拔出注入器1 0a。 作爲上述之體液漏出防止劑X，除了含有高吸水性樹 脂粉末之凝膠狀之體液漏出防止劑，亦可使用高吸水性樹 脂粉末或將其壓縮整形者、或高吸水性樹脂粉末與纖維等 之充塡材料一同壓縮整形者等。作爲凝膠狀之體液漏出防 止劑，雖可使用傳統已知之凝膠狀之各種體液漏出防止劑 ，但以使用上述之本發明相關之凝膠狀之體液漏出防止劑 爲宜。體液漏出防止材料含有或保持高吸水性樹脂粉末， 因爲吸收體液及污物中液體之高吸水性樹脂粉末膨脹（倂 用吸水性纖維狀充塡材料時，該部份滲透於吸水性纖維狀 充塡材料），成爲固體狀凝膠，所以可確實地防止體液及 污物漏出。 另一方面，上述纖維狀充塡材料Y係可以高吸水性 樹脂纖維之不織物、壓縮紙漿紙、棉、棉及高吸水性樹脂 纖維混紡、高吸水性樹脂纖維等之成形物、合成纖維之不 織布、布等形成，但尤其以使用水膨潤性纖維，例如丙烯 酸纖維之內層及由吸水性樹脂所形成之外層所構成之東洋 紡績股份有限公司製之 LANSEAL(註冊商標）F 或 LANSEAL(註冊商標）K成形成圓柱形者，或壓縮成形紙漿 成圓柱形者（例：女性用衛生棉條型）爲宜。另外，成形各 -31 - 200913976 種纖維成球狀者亦可。 例如含高吸水性樹脂粉末之壓縮整形體或組合吸收體 液時迅速膨脹而成爲固體狀凝膠之凝膠狀體液漏出防止劑 X ’及吸水性纖維狀充塡材料γ使用時，於注入器之筒狀 本體的內部，自吐出口側依序收納含高吸水性樹脂粉末之 壓縮整形體或凝膠狀之體液漏出防止劑，及吸水性纖維狀 充塡材料，筒狀本體先端之吐出口係由封閉材料裝卸自由 地封閉。藉由如此構成，不必取下封閉材料，可直接將含 高吸水性樹脂粉末之壓縮整形體或凝膠狀之體液漏出防止 劑及吸水性纖維狀充塡材料一同注入、裝塡於體腔內。因 此，可作業性佳，簡便地、且衛生地進行遺體之肛門或陰 道之封閉作業。另外，此時，因爲吸收體液及污物中液體 之體液漏出防止材料中之高吸水性樹脂粉末膨脹，並且， 該部份滲透於吸水性纖維狀充塡材料，成爲固體狀凝膠， 所以可確實地防止體液及污物漏出。 另外，於上述之實施型態，圓筒狀構件21a先端之吐 出口部份22a係向著半徑方向中心，向外側彎曲，藉由沿 線存在之多數個舌片28而形成約半球狀，但圓筒狀構件先 端之吐出口亦可爲如切斷圓筒體之端面之圓形。此時’切 斷圓筒體之先端部份必須由保護蓋（封閉構件）封閉。作爲 保護蓋（封閉構件）係除了如上述圖7及圖8所示之約略半球 狀之圓頂狀型態之外’亦可爲於切斷圓筒體之先端部份內 ，嵌入盤狀或圓形板狀之內蓋以堵住吐出口 ’自上方於先 端部份冠上圓頂狀之蓋構件之型態、使用具有直徑大於圓 -32- 200913976 筒體內徑之半球部份，及具有直徑大約與圓筒體內徑相同 之圓棒部份成爲一體之菇型形狀之保護蓋（封閉構件），嵌 入該圓棒部份於圓筒體先端以堵住吐出口之型態、嵌入具 有任一種具有直徑與圓筒體內徑相同之半球部份及與圓棒 部份成爲一體之形狀之保護蓋（封閉構件）於圓筒體先端以 堵住吐出口之型態中之任一種。 作爲上述保護蓋（封閉構件）之材質，可使用由牛脂、 椰子油、棕櫚油等所製作之固體皂、或聚乙二醇（PEG， 以平均分子量約爲1 0 00以上之固體物）、塑膠材料，尤其 聚乙烯（PE)、聚丙烯（PP)、聚醯胺（PA，別名：尼龍）等之 熱可塑性塑膠、橡膠、高吸水性樹脂纖維等之成型物、壓 縮成形紙漿成圓柱形者（例：女性用衛生棉條型）、棉及高 吸水性樹脂纖維混紡、合成纖維或天然纖維之成型不織布 、塑膠發泡體（獨立氣泡泡沫）、木材、軟木塞等。 如上述之自鼻孔插入，注入、裝塡體液漏出防止劑於 咽喉部份用之處理裝置、及注入、裝塡體液漏出防止劑於 肛門及/或陰道用之處理裝置，與防止自耳孔及/或鼻孔漏 出體液用之纖維製封閉材料、或另外口中裝塡用之纖維製 封閉材料一同收納於一個容器內，構成爲遺體處理裝置單 元爲宜，因此而攜帶方便，可迅速地進行遺體處理。 作爲防止自耳孔及/或鼻孔漏出體液用之纖維製封閉 材料’可適合使用由棉、高吸水性樹脂纖維、棉及高吸水 性樹脂纖維之混紡及不織物而成，成形成球形、柱狀、立 方體等所需的形狀者。以備有耳塞用2個及鼻塞用2個之封 -33- 200913976 閉材料爲宜。 另外，口中裝塡用之纖維製封閉材料係放入臉頰內， 以防止體液漏出及形成臉頰膨起近似於自然膨起爲目的者 ’可適合使用如上述之棉、棉及高吸水性樹脂纖維混紡、 高吸性樹脂纖維等之布或不織物、或棉及高吸性樹脂纖維 之不織物之單品材料、或將此等單品材料以任意之層結構 ’層合成三明治狀之材料所形成之封閉材料。 圖9係表示有關本發明之體液漏出防止劑注入用插入 管之先端部份變形例。 於此變形例中，如圖9所示，插入管本體40a之先端 部份係藉由向著半徑方向中心，向外側彎曲延伸之多數舌 片45，形成約半球狀，及由該多數舌片45之先端所形成之 開口與舌片間空隙而成之開口部份所形成。各舌片45係具 有可向外側彎曲之柔軟性。因此，由活塞壓出注入器所充 塡之體液漏出防止劑時，體液漏出防止劑撐開多數舌片而 壓出，並且，因爲自擴張開的舌片間之間隙亦壓出，所以 該表面積變大。 圖1 〇係表示有關本發明之體液漏出防止劑注入用插入 管之其他實施型態。 於此實施型態中，除了自先端部份之所定位置，使插 入管本體4 0a彎曲以外，與上述圖5所示插入管相同。藉 由形成如此之彎曲部份46，自鼻孔插入至咽頭部位深處時 ，可無阻力順利地插入。此時，使彎曲的位置係自插入管 本體40a之先端約22〜45mm，以距離約爲20〜30mm之任 -34- 200913976 意部份爲宜，另外，彎曲角度爲0〜95。，以30〜70°爲宜 〇 上述各實施型態中，於插入管本體40a之後端部份與 連接部份43—體成形，但連接部份43亦可爲不同個體，該 一例如圖1 1所示。 預先分別製作插入管主體40a，於連接部份43之先端 部份所形成之凹陷部份48，插入插入管主體40a之後端部 份4 7，由例如黏合劑、焊接等之適當手段黏合。如此地以 插入管主體40a及連接部份43爲分別個體時，連接部份43 係以剛性合成樹脂形成爲宜。另外，此實施型態時，制止 部份44亦可形成於連接部份4 3之先端。 以上係參照附圖下’說明本發明之遺體處理裝置之各 種型態之適合具體例，但本發明之凝膠狀之體液漏出防止 劑亦可由傳統已知之注入器注入、裝塡於遺體之口、鼻、 耳、肛門、女性之陰道等之體腔，封閉液體，當然並不侷 限於上述各型態者。 以下係表示具體地確認本發明之體液漏出防止劑之功 效之實施例及試驗例’但當然本發明並非侷限於如下之實 施例者。另外’於下述中，除非例外，「％」係指「質量 %」。 試驗例1 (試驗原料之發熱溫度測定試驗） 試驗方、法： 坪量10g之表1所示之各原料，放入於3〇ml之燒杯， -35- 200913976 接著，以下述條件測定注入8 g之離子交換水時混合液之 發熱溫度。 測定器：安立計器（股）製DATA COLLECTOR之液體 用溫度感應器。 測定時之室溫：2 2.3 t。 試驗結果係如表1所示。 表1 原料名 試驗次數 初期原料溫度 (°C ) 剛混合後之液溫 rc ) 90秒後之液溫 (°C ) PEG200 第1次 23.9 35.0 31.7 第2次 25.1 37.8 33.1 無水甘油 第1次 24.9 28.0 26.8 第2次 25.2 28.5 27.2 乙二醇 第1次 24.7 27.9 26.9 第2次 24.7 28.9 27.0 乙醇 第1次 24.2 28.0 26.5 第2次 24.5 28.2 26.6 備考 PEG200 :聚合度之平均分子量爲200之聚乙二醇 如上述表1所示，液狀PEG200時，與水混合時立即發 熱，迅速地可溶於水，並且可維持該溫度程度某些程度之 時間。相對於此，醇系溶劑之無水甘油、乙二醇、乙醇時 ，與水混合後僅些微發熱，該溫度程度相當低，並且亦不 能維持該溫度程度。由此可知，液狀PEG200係適合於提 高高吸水性樹脂之吸液速度，迅速地凝固成無流動性之固 體凝膠狀，最適合作爲達成防止體液漏出防止之體液漏出 -36 - 200913976 防止劑之基劑。 實施例1〜3及比較例1、2 如表2所示之配合比率，於溶解聚環氧乙烷系之熱可 塑性之非離子型吸水性樹脂於聚乙二醇200之液體中，使 高吸水性樹脂粉末均勻地分散，調製體液漏出防止劑（實 施例1〜3 )。另外，用以比較，溶解作爲凝膠化劑之丙烯 酸聚合物（羧乙烯基聚合物之鹼鹽）於醇系溶劑之乙二醇之 液體中，使高吸水性樹脂粉末均勻地分散，調製體液漏出 防止劑（比較例1、2)。 如此調製之體液漏出防止劑之吸水速度及狀態係由下 述之試驗方法進行比較。 試驗例2(試驗試樣之吸水速度試驗） 試驗方法： 秤量lg之試驗試樣，放入於l〇〇ml之燒杯，接著注入 8 0ml之離子交換水（2 (TC )，測定全部離子交換水成爲凝膠 狀之時間。 試驗結果係如表2所示。 -37- 200913976 表2 試驗試樣No. 實施例No. 比較例No. 1 2 3 1 2 處 方 PEG200 75% 80% 85% 乙二醇 — _ _ 79.4% 89.4% 羧乙烯基聚合物 _ • _ 0.2% 0.2% 三乙醇胺 0.4% 0.4% 高吸水性樹脂粉末 20% 15% 10% 20% 10% 熱可塑性非離子型吸水樹脂 5% 5% 5% 合計 100% 100% 100% 100% 100% 結 果 至成爲凝膠狀之時間(秒） <3次平均> 102 178 522 510 未开多成 凝膠 備 考 羧乙烯基聚合物：商品名「Hibiswaco*」和光純藥工業(股)製 高吸水性樹脂粉末：商品名1QUA-KEEP*」住友精化(股)製 熱可塑性非離子型吸水性樹脂：商品名^AQUA-COKE」住友精化(股)製 1註冊商標 如上述表2所示之結果顯示，即使高吸水性樹脂粉末 之添加量爲相同之1 〇質量％，使用乙二醇作爲基劑之比較 例2時，不能形成凝膠狀，相對地使用液狀之PEG200之實 施例3可形成凝膠狀。另外，於比較例2中，使高吸水劑樹 脂粉末均勻地分散需要5 5分鐘，而且，液體狀態爲稀稀的 水溶液。由此可知，使用醇系基劑時，調製體液漏出防止 劑需要長時間，作業性差。另外，高吸水劑樹脂粉末之添 加量即使爲相同的20質量％，使用乙二醇作爲基劑之比較 例1時，至形成凝膠狀之時間長達5 1 0秒，相對地使用 PEG2 00之實施例1以102秒可形成凝膠狀。由此可知，本 發明之體液漏出防止劑係迅速地凝固成無流動性之固態凝 -38- 200913976 膠狀，最適合作爲達成防止體液漏出之體液漏出防止劑。 試驗例3 (試驗原料之發熱溫度測定試驗） 試驗方法： 秤量20g之表3所示之各原料，放入於50ml之燒杯， 接著，以下述條件測定注入1 6g之離子交換水時之混合液 之發熱溫度。 測定器：醇棒狀溫度計（溫度範圍爲〇〜50°C )。 測定時之室溫：1 8.5 °C。 離子交換水之溫度：1 8.0 °C。 試驗結果係如表3所示。 表3 原料名 (商品名） 試驗次數 初期原料 溫度(°C) 混合30秒後 之液溫 rc) 混合60秒後 之液溫 ΓΟ 混合120秒 後之液溫 CC) SANNONIC SS-120 第1次 18.0 27.1 28.3 27.0 第2次 18.0 27.5 28.7 27.3 SANNONIC FN-100 第1次 18.0 27.5 28.0 27.2 第2次 18.0 26.8 27.9 27.0 SORGEN TW-60V 第1次 18.0 25.1 25.8 25.6 第2次 18.0 25.5 26.2 25.8 備考 SANNONIC SS-120 :聚環氧乙烷烷基醚 三洋化成工業(股)製非離子性界面活性劑之商品名 SANNONIC FN-100 :聚氧化烯烷基醚 三洋化成工業(股)製非離子性界面活性劑之商品名 SORGEN TW-60V :聚環氧乙烷山梨糖醇酐單硬脂酸酯 第一工業製藥(股)製非離子性界面活性劑 〃註冊商標 -39- 200913976 如上述表1所示，非離子性界面活性劑與水混合時立 即發熱。上述試驗中之非離子性界面活性劑與水之混合比 率，混合液雖成爲相當黏稠的液體’但非離子性界面活性 劑係迅速地可溶解於水。由此’非離子性界面活性劑提高 高吸水性樹脂之吸水速度’迅速地凝固成無流動性之固態 凝膠狀，最適合作爲達成防止體液漏出之體液漏出防止劑 之基材。 實施例4〜7 秤量 60 〜80g 之 SANNONIC SS-120 於 3 00ml 之燒杯， 設置於加熱板上，於攪拌下加熱成60°C〜80t後，緩緩加 入分散安定劑（5g之聚環氧乙烷系之熱可塑性非離子型吸 水性樹脂粉末或另外的1 〇g之聚乙二醇），使溶解成黏稠 液後，恢復成室溫，緩緩地加入（15g〜25g)高吸水性樹脂 粉末，調製凝膠狀之體液漏出防止劑。 將如此調製之體液漏出防止劑之吸水速度及狀態，依 據與上述試驗例2 (試驗試樣之吸水速度試驗）相同的試驗 方法比較。 試驗結果係如表4所示。 -40- 200913976 表4 試驗試樣 實施例No. 4 5 6 7 處 方 SANNONIC SS-120 70% 75% 80% 60% PEG#200 10% 熱可塑性非離子型吸水樹脂粉末 5% 5% 5% 5% 高吸水性樹脂粉末 25% 20% 15% 25% 合計 100% 100% 100% 100% 結 果 至成爲凝膠狀之時間(秒） <3次平均> 113 181 348 118 備 考 SANNONIC SS-120(商品名）：聚環氧乙烷院基醚 三洋化成工業(股)製非離子性界面活性劑 PEG#200(商品名）：聚合度之平均分子量爲200之聚乙二醇、日本油脂(股)製 熱可塑性非離子型吸水性樹脂粉末：商品名「aqua-keep*」 住友精化(股)製 高吸水性樹脂粉末：商品名^AQUA-COKE*」住友精化(股)製 * =註冊商標 如上述表4所示之結果顯示，若高吸水性樹脂粉末之 添加量少時，至成爲固態凝膠狀之吸水速度變慢。上述表 2及表4對照時顯示，關於吸水速度上，如實施例1之以 PEG # 200爲基材之凝膠狀體液漏出防止劑至成爲無流動 性之固態凝膠狀之時間快，並且外觀性狀亦佳。因此，作 爲凝膠狀體液漏出防止劑之基材，以聚乙二醇最適合。 實施例8 秤量68g之PEG # 200於3 00ml之燒杯，設置於加熱板 上，於攪拌下加熱成6(TC〜80°C後，緩緩加入7g之親油 -41 - 200913976 性蒙脫石，使溶解成黏稠液後’恢復成室溫’緩緩地加入 25g之高吸水性樹脂粉末’調製凝膠狀之體液漏出防止劑 〇 將如此調製之體液漏出防止劑之吸水速度及狀態’依 據與上述試驗例2(試驗試樣之吸水速度試驗）相同的試驗 方法比較。 試驗結果係如表5所示。 表5 試驗試樣 質量％ 一 處 PEG #200 ... 68.00% _ 方 親油性蒙脫石 7.00% 高吸水性樹脂粉末 25.00% 一 合計 100.00% 結 至成凝膠狀之時間 89 果 (秒)(3次平均） 備 PEG#200(商品名）：聚合度之平均分子量爲200之聚乙二醇、 考 曰本油脂(股)製 親油性蒙脫石：商品名「RusentiteSPNccl5」、CO-OPChemidal(股)製 高吸水性樹脂粉末··商品名「aqua-keep*」、住友精化(株)製 ^註冊商標 如上述表5所示，即使使用親油性蒙脫石作爲分散安 定劑，仍可調製凝膠狀之體液漏出防止劑’另外’於吸水 試驗中，至形成固態凝膠狀之時間非常快’作爲體液 '漏出 防止劑之分散安定劑係良好的物質。 -42- 200913976 【圖式簡單說明】 圖1係表示傳統的遺體處理裝置之使用狀態之槪略斷 面圖。 圖2係表示有關本發明之遺體處理裝置之一種實施型 態，（A)爲正面圖’（B)係左側面圖，（c)右側面圖。 圖3係表示沿著圖2所示之遺體處理裝置之中心軸線之 縱斷面圖。 圖4係表示沿著圖2所示之遺體處理裝置之中心軸線之 橫斷面圖。 圖5係表示有關本發明之遺體處理裝置之插入管之縱 斷面圖。 圖6係表示有關本發明之遺體處理裝置之其他實施型 態’（A)爲正面圖，（B)係左側面圖，（C)右側面圖。 圖7係表示沿著圖6所示之遺體處理裝置之中心軸線之 縱斷面圖。 圖8係表示沿著圖6所示之遺體處理裝置之中心軸線之 橫斷面圖。 圖9係表示有關本發明之遺體處理裝置之插入管之先 端之其他實施型態之部份側面圖。 圖1〇係表示有關本發明之遺體處理裝置之插入管之其 他實施型態之部份側面圖。 圖11係表示有關本發明之遺體處理裝置之插入管之另 外其他實施型態之部份斷面圖。 -43- 200913976 【主要元件符號說明】 l，10，10a:注入器 20,20a:筒狀本體 2 1,2 1 a :圓筒狀材料 22,22a:吐出口部份（吐出筒部份） 2 3,2 3 a :停止部份 24 :突出條狀部份 2 5，2 5 a :覆蓋構件 26 :凸緣部份 27,44 ：制止部份 28 :舌片 29,29a :保護蓋 3 0 :活塞 3 1 :活塞桿 3 2 :圓形凸緣部份 3 3 :凸緣部份 34 :橡膠墊 3 5 :圓板狀部份 40 :插入管 40a:插入管本體 42 :開孔部份 43 :連接部份 45 :舌片 46 :彎曲部份 -44 - 200913976 χ:體液漏出防止劑 Y :纖維狀充塡材料 A :鼻孔 B :咽喉部份 C :舌 D :氣管 E :食道 -45200913976 IX. INSTRUCTIONS OF THE INVENTION [Technical Field] The present invention relates to a gel which is closed by a body cavity attached to the mouth, nose, ear, anus, and female vagina of a body to prevent leakage of body fluid from the body. The body fluid leakage preventing agent, the injector and the insertion tube used for injecting the body fluid into the body cavity, and the body treatment device using the same. [Prior Art] In general, humans or animals have muscle relaxation in various parts of the body cavity after death, and body fluids such as gastric juice, lung fluid, ascites, and excretions are often leaked out, causing malodor or infection due to pathogenic bacteria. Therefore, for example, in a hospital, after confirming death, a large amount of gauze, absorbent cotton, etc. are attached to the body cavity of the body's mouth, nose, ear, anus, and female vagina to prevent leakage of body fluid, and, in addition, after an accident or surgery The same part of the opening of the remains is treated the same. However, the work of installing gauze and absorbent cotton equal to the body cavity is mostly carried out by a practitioner or a nurse, etc., which is troublesome or unsanitary, and because the gauze, the absorbent cotton, etc. have low water absorption capacity, and are in operation or The problem of frequent leakage of body fluids after work, or the possibility of infection after death due to leakage of material during work, is strongly demanded. For this reason, it is known to replace the gauze, the absorbent cotton, and the like with the superabsorbent resin powder in the mouth, the nose, the ear, the throat, and the like. For example, a method of attaching the super absorbent resin powder to the mouth, the nose, and the ear using a syringe is known (refer to JP-A No. 1 0 -29 8 0 01), a method of using a water-absorbent resin powder containing stabilized chlorine dioxide, directly using a powder in a throat, and encapsulating a noodle hole, -4-200913976 nostril with a water-soluble sheet ( Reference Japanese Patent Publication No. 7-2653 67). However, even if such a highly water-absorbent resin powder is contained, it is difficult to mount it in a narrow body cavity such as a throat portion or an anus because of poor fluidity. In addition, when it is only the entrance portion of the nasal hole or the ear hole, such a fine powder can be filled as an injector of a syringe, but it cannot be filled deep. In addition, in order to fill the depths, the syringe must be filled while moving, and the fine powder from the apex is scattered, which in turn contaminates the surrounding body. In order to solve the problems of the high water-absorbent resin powder such as the chargeability or poor workability, or scattering, it has been proposed in recent years to use a gel instead of a powder, and it is known to use, for example, a powder polymer in which a deodorant is added by dissolving an appropriate amount of water. , a method of appropriately mixing a gelatinous substance (refer to Japanese Laid-Open Patent Publication No. Hei 8-1-33 90 1), or a method of using an amphoteric gel containing dimethyl acrylamide as a main component (refer to JP-A-2001- Japanese Patent No. 288002), a method of dispersing a plurality of superabsorbent polymer powders in a gel containing an alcohol as a main component (refer to Japanese Patent No. 3,586,207). In the case of filling the throat portion of the gelled body fluid leakage preventing agent, for example, in the throat portion deep in the nostril, as described below with reference to Fig. 1, the gelatinous body fluid is stored as described in Japanese Patent Laid-Open No. 35-862 07 The leakage preventing agent 2 is provided in the injector 1 in a sealed state in which the piston 3 that is slidably inserted from the rear end and the injection port 4 of the tip covering protective cover 5 are wrapped in a film package (not shown). The insertion tube 6 inserted into the body cavity of the throat portion B has a connecting portion 7 connected to the injection port 4 of the injector 1, and the other end has an opening portion 8 inserted into the nostril A. Next, a method of using the thus prepared body treatment device will be described. Figure -5- 200913976 1 A, nostril, B-throat, c-lingual, D-line, E-esophagus. In use, the injector 1 is taken out from the film package, the protective cover 5 of the inlet 4 of the injector 1 is removed, and the connecting portion 7 of the insertion tube 6 is inserted into the injection port 4 to connect the insertion tube 6. Next, the opening portion 8 of the insertion tube 6 is inserted from the nostril A toward the throat portion B, and when the stopper portion 9 of the insertion tube 6 hits the nose tip B, the insertion is stopped. Next, the piston 3 of the inserter 1 is pushed, and the gel-like body fluid leakage preventing agent 2 in the injector 1 is injected into the throat portion B via the insertion tube 6. The gel-like body fluid leakage preventing agent 2 in the injector 1 is pushed out, and after filling, the injector 1 and the insertion tube 6 are removed from the nostril A. The gel-like body fluid leakage preventing agent as described above has a high fluidity, and even a narrow body cavity such as a nostril or an ear hole is easily filled, even if it is pressed by an injector and does not scatter. In particular, when a gel of a plurality of superabsorbent polymer powders is dispersed, water absorption performance is high, and the polymer absorbs body fluid leaking from the body cavity to prevent leakage to the outside. However, since the conventional gel-like fluid leakage preventing agent is injected at an injection device and is slowly attached to the body cavity, the body fluid is easily leaked due to the relaxation of muscles in various parts of the body cavity after death. In addition, it is not sufficient for the liquid absorbing ability just after being injected and mounted in the body cavity. In addition, when the conventional injector and the insertion tube are combined, the operability is problematic, and since the middle portion of the elongated insertion tube has a mark or a stop portion indicating the insertion stop position, it is necessary to be skilled in the insertion of the insertion tube. It is difficult to accurately inject and fix the body fluid leakage preventing agent at a certain application site. SUMMARY OF THE INVENTION -6 - 200913976 DISCLOSURE OF THE INVENTION PROBLEM TO BE SOLVED BY THE INVENTION Therefore, the basic object of the present invention is to provide rapid absorption of body fluids when injecting into a body cavity by an infusion device and contacting body fluids in a body cavity. The body fluid leakage preventing agent which is swelled and solidified, and can effectively prevent the body fluid from leaking out. Another object of the present invention is to provide a body fluid leakage preventing agent which is excellent in workability, and to store the body fluid leakage preventing agent in the body cavity of the body, and to perform the sealing operation of the body cavity easily, surely and hygienically, and to effectively and surely prevent leakage of body fluid The body treatment device. Another object of the present invention is to provide a body fluid leakage preventing agent which is excellent in operability, and which is not required to be inserted into an insertion tube, and can be surely applied to a site where the application body is often applied, and the body fluid leakage preventing agent is injected. Insert the tube and the body treatment device using the same. Solution to Problem In order to achieve the above object, the present invention provides a liquid substrate (A) containing at least one selected from the group consisting of polyethylene glycol and a nonionic surfactant, which is heated when mixed with water, and at least one selected Self-polyepoxide-based thermoplastic nonionic water-absorbent resin, carboxyvinyl polymer of acrylic polymer, alkali salt of carboxyvinyl polymer of acrylic polymer, lipophilic montmorillonite, synthetic hectorite In the viscous liquid base of the dispersion stabilizer (B) in which the natural hectorite and the bentonite are grouped, the body fluid leakage preventing agent which is a body characterized by the dispersion of the super absorbent resin powder (C) is dispersed. 200913976 In a suitable form, the dispersion stabilizer (B) is a polyepoxide-based thermoplastic nonionic water-absorbent resin. Further, the body fluid leakage preventing agent of the present invention may further contain either or both of the water-soluble alcohol-based organic solvent (D) and the tackifier (E), and may further contain at least one selected from the group consisting of sterilization. Agents, mildew, preservatives, deodorants and fragrances. Further, according to the present invention, there is provided a flange portion having a discharge port portion or a discharge cylinder portion at the tip end, and a flange portion protruding from the radial direction at the rear end portion, and a body fluid leakage preventing agent is accommodated therein. A cylindrical body body and a treatment device having a body characterized by an injector that is slidably inserted into the cylindrical body from the rear end portion side. In a suitable form, the cylindrical system of the injector has a cylindrical member having a discharge port portion or a discharge cylinder portion at a tip end, and a cover member covering the outer periphery, and the piston system is slidably inserted In the above cylindrical member. According to a more specific aspect of the present invention, there is provided a treatment device for inserting a nasal cavity into a body, for injecting and mounting a body fluid leakage preventing agent in a throat portion, and having a flexible synthetic resin insertion tube; and having a connection at the tip end a portion of the discharge tube for inserting the tube, and a cylindrical body having a flange portion protruding from the finger in the radial direction at the rear end portion, and having a freely slidable insertion from the rear end portion side The injector of the piston in the tubular body is a body treatment device characterized by a body fluid leakage preventing agent inside the cylindrical body. In a suitable form, the cylindrical system of the injector has a cylindrical member having a discharge tube portion at a tip end, and a cover member covering the outer periphery. -8-200913976 Cover the component. The insertion tube is a normal insertion tube of the apex opening or an insertion tube having one or more opening portions in the side wall adjacent to the apex portion, but the apex portion is formed into a hemispherical shape and The side has an opening portion, and the rear end portion has a connecting portion for connecting the discharge barrel portion of the injector. In other suitable embodiments, the distal end portion of the insertion tube is formed by a plurality of tongues extending outward toward the center in the radial direction to form an approximately hemispherical shape, and an opening and a tongue formed by the apex of the plurality of tongues. An opening portion formed by the gap between the sheets is formed, and a connecting portion for connecting the discharge tube portion of the injector is provided at the rear end portion. In any of the above-described types, the insertion tube has a stopper portion protruding outward in the radial direction at a position having a distance from the rear end. Further, it is preferable that the insertion tube has a bent portion at a position having a distance from the tip end. More specifically, the other embodiment of the present invention is an anal and/or vaginal treatment device for injecting and mounting a body fluid leakage preventing agent on a body, having a spout portion at the tip end and hooking at the rear end portion a cylindrical body protruding from the flange portion on the outer side in the radial direction, and an injector having a piston slidably inserted into the cylindrical body from the rear end portion side inside the cylindrical body A body treatment device characterized by a body fluid leakage preventing agent. In the treatment device, as the body fluid leakage preventing agent, a gel-like body fluid leakage preventing agent containing the superabsorbent resin powder, a super absorbent resin powder, or a compression plasticizer or a superabsorbent resin can be used. The powder is compressed and shaped together with the filling material such as fiber, or alone or -9 - 200913976 combined water-absorbing fibrous filling material. In the inside of the cylindrical body, a compression-shaping body or a gel-like body fluid leakage preventing agent containing a super absorbent resin powder and a fibrous filling material, particularly a water-absorbent fibrous charge, are sequentially stored from the side of the discharge outlet portion.塡 materials are appropriate. With respect to the appropriate type, the discharge port portion at the tip end of the cylindrical body is formed by a plurality of tongues bent outward toward the center in the radial direction to form a hemispherical shape and formed by the tip end of the plurality of tongues. The opening portion formed by the gap between the opening and the tongue is formed. Further, it is preferable that the front end of the cylindrical body can cover the detachable protective cover of the discharge port portion. Regarding the appropriate type, the intermediate portion of the cylindrical body has a stopper portion that protrudes outward in the radial direction. More preferably, the cylindrical system has a cylindrical member having a discharge port at a tip end, and a cover member covering the periphery, and the flange portion is provided at a rear end portion of the cylindrical member. The stopper portion is provided at a predetermined position of the covering member, and the piston is slidably inserted into the cylindrical member. According to another aspect of the present invention, there is provided a flexible synthetic resin insertion tube, the tip end portion being formed into a hemispherical shape and closed, and on the side surface, the insertion tube body having a plurality of opening portions, and the insertion tube a connecting portion of the discharge cylinder portion of the injector having a body fluid leakage preventing agent disposed at a rear end portion of the body, and having a stopper portion protruding outward in a radial direction at a predetermined position of the connecting portion is characterized The insertion tube for injecting the body fluid leakage preventing agent of the body. -10- 200913976 According to another specific type, a flexible synthetic resin insertion tube is provided. The tip end portion of the insertion tube is formed into a hemispherical shape by bending a plurality of tongues extending outward toward the center in the radial direction. And an insertion tube body formed by the opening portion formed by the gap between the opening formed by the front end of the plurality of tongues and the tongue, and the rear end portion of the insertion tube body is provided for connecting body fluid leakage The connecting portion of the discharge tube portion of the injection preventing agent has a body fluid leakage preventing agent injection insertion tube characterized by a stopper portion protruding outward in the radial direction at a predetermined position of the connecting portion. Regarding the insertion tube of any of the above types, the insertion tube system preferably has a curved portion at a distance from the front end. Further, according to the present invention, a body processing apparatus as a kit is also provided. One processing device is characterized by an insertion tube for injecting a body fluid leakage preventing agent including the above-described processing device and the above-described body. The other body treatment device includes the above-mentioned treatment device for inserting and squeezing a body fluid leakage preventing agent into the throat portion, and the above-mentioned injection/assembly body fluid leakage preventing agent for anal and/or vaginal treatment. The device, and a fibrous closure material that prevents leakage of body fluids from the ear canal and/or nostrils. As the body treatment device of this set, it is also preferable to use a fiber-made sealing material which is more suitable for the mouth. The effect of the invention is that the body fluid leakage preventing agent of the body of the present invention contains a liquid substrate (A) which is selected from the group consisting of polyethylene glycol and a nonionic surfactant, and which generates heat when mixed with water, and at least one kind Thermoplasticity selected from the group consisting of polyepoxides - 200913976 Subtype water absorbent resin, carboxyvinyl polymer, alkali salt of carboxyvinyl polymer, lipophilic smectite, synthetic hectorite, natural In the viscous liquid base of the dispersion stabilizer (B) in which the montmorillonite and the bentonite are grouped, the gel of the superabsorbent resin powder (C) is dispersed, so that it is injected and attached to the body by the injection device. When the body cavity is in contact with the body fluid in the body cavity, the liquid absorption rate of the superabsorbent resin powder (C) is increased by the heat generation of the liquid substrate (A), and the body fluid is quickly absorbed, swollen, and solidified into no fluidity. The solid gel form (solid gel) can effectively prevent leakage of body fluid. Further, according to the suitable form of the body fluid leakage preventing agent of the present invention, since the dispersion stabilizer (B) is a polyepoxide-based thermoplastic nonionic water-absorbent resin, it is possible to more reliably maintain contact with body fluids. The superabsorbent resin powder (C) is uniformly dispersed. Therefore, the polyepoxide-based thermoplastic nonionic water-absorbent resin acts as a body fluid leakage preventing agent for the dispersion stabilizer, and when it is injected or attached to the body cavity of the body, it absorbs the body fluid rapidly, swells and solidifies into no flow. The solid solid gel shape can prevent the leakage of body fluid more effectively. Further, the body fluid leakage preventing agent of the present invention further comprises either or both of a water-soluble alcohol-based organic solvent (D) as a co-solvent and a viscosity-increasing agent (E) for improving fluidity. It is easy to adjust the viscosity, and the flowability can be improved, and the narrow body cavity such as the throat portion can be more smoothly injected and attached. Further, by containing at least one selected from the group consisting of a bactericide, a mildew preservative, a deodorant, and a fragrance, the desired effects can be exhibited. Further, the 'body processing apparatus of the present invention is provided with a cylindrical body having a discharge port portion at the tip end and a flange portion protruding from the outer side of the radial direction -12-200913976 at the rear end portion, and An injector having a piston that is slidably inserted into the cylindrical body from the side of the rear end portion, and the body fluid leakage preventing agent is accommodated in the cylindrical body, so that the body fluid leakage preventing agent is injected and attached to the body In the case of the body cavity, the above-mentioned effects are exerted, and since the rear end portion of the cylindrical body has the flange portion for hooking the finger, the injection operation of the body fluid leakage preventing agent for the body cavity of the body can be performed more easily. . The cylindrical system of the above-described injector is formed by a cylindrical member having a discharge port portion or a discharge cylinder portion at the tip end, and a cover member covering the periphery, because the flange portion is provided Since the cylindrical member or the covering member is used, the cylindrical body can be manufactured at a low cost and easily compared with the case of integral molding, by making the covering member into a polygonal shape of a cross section, or by coloring or coloring the covering member. This color is made different from the color of other members to form a color injector, which can be easily discriminated by the nurse in the hospital without mistakenly thinking of a general syringe, or clearly grasping the application site. In addition, a suitable type of a treatment device for injecting and mounting the above-described body fluid leakage preventing agent into the throat portion is formed by the tip end portion of the flexible synthetic resin insertion tube formed into a hemispherical shape, and The side has an opening portion, so that the insertion tube can be smoothly inserted from the nostril to the throat portion, and there is no insertion tube having an opening at the apex end, and the apex opening is blocked when it contacts the application site, and it is difficult to prevent leakage of body fluid. The problem of the agent can be smoothly injected and sealed with the body fluid leakage preventing agent. On the other hand, according to other suitable types of the insertion tube, since the flexible synthetic resin is inserted into the tip end portion of the tube body, a plurality of tongues extending outward are bent toward the outside in the center of the radial direction -13-200913976. The hemispherical shape is formed by an opening formed by the opening formed by the apex of the majority of the tongue and the gap between the tongues, and the body fluid leakage prevention is prevented when the piston is pressed out of the body fluid leakage preventing agent filled in the injector. The agent is pushed out by a large number of tongues, and since the gap between the self-expanded tongues is also pressed out, the surface area becomes large. Therefore, when it comes into contact with the body fluid in the body cavity, it will quickly absorb the liquid to form a solid gel with no fluidity, which will prevent the leakage of body fluid more effectively and quickly. Further, it is preferable to position the connecting portion of the rear end of the insertion tube at a position to connect the connection portion of the discharge tube portion of the injector, since the stopper portion protruding from the outer side in the radial direction is inserted with the slender insertion When the middle portion of the tube is provided with the stopper portion, the length of the insertion tube can be shortened, and the insertion insertion tube can be smoothly performed without being skilled, and the opening portion can be surely located at a certain application site, and can be injected and loaded. The body fluid leakage preventing agent 〇 and then according to the appropriate type of the insertion tube, since the above-mentioned insertion tube system has a curved portion from a position determined by the distance from the anterior end, the insertion of the nostril into the deep part of the pharyngeal portion can be smoothly performed without resistance. Insert the insertion tube. On the other hand, the treatment device for the anus and/or vagina for injecting the body fluid leakage preventing agent into the body of the body is contained in the interior of the cylindrical body of the injector, and the water absorption property is sequentially stored from the side of the discharge port. A compression-shaping body of a resin powder or a gel-like body fluid leakage preventing agent, and a fibrous filling material, particularly a water-absorbent fibrous filling material, which absorbs body fluids and liquids in the body when injected into a body cavity The superabsorbent resin powder in the body fluid leakage preventing agent is swollen, and since it partially penetrates into the fibrous material-filled material, it becomes a solid gel, so that it is possible to reliably prevent leakage of body fluids and dirt. In addition, at the apex of the cylindrical body, when the cover can cover the detachable protective cover of the spout portion, it is not necessary to remove the protective cover, and the body fluid leakage preventing agent and the fibrous filling material can be directly injected together. . Therefore, it is possible to perform the operation of the anus or vagina of the remains easily and hygienically. With respect to the appropriate type, the discharge portion of the apex of the cylindrical body is formed by a plurality of tongues bent outward toward the center in the radial direction to form a hemispherical shape, and is formed by the apex of the plurality of tongues. The opening portion formed by the gap between the opening and the tongue is formed, and can be smoothly inserted into the anus and/or the vagina, and when the body fluid leakage preventing agent is filled by the piston, the body fluid leakage preventing agent spreads off most of the tongue and presses And, since the gap between the self-expanded tongues is also pressed out, the surface area becomes large. Therefore, when it comes into contact with body fluids in the body cavity, it will quickly absorb liquid to form a liquid-free solid gel, which will prevent body fluids from leaking out more effectively. In addition, since the intermediate portion of the cylindrical body has a stopper portion that protrudes outward in the radial direction, it is not necessary to skillfully insert the opening portion of the insertion tube or the discharge portion of the injector to be surely located frequently. A certain application site, injection, and body fluid leakage prevention agent and fibrous filling material. Further, as the body treatment device of the kit of the present invention, it is provided with a treatment device for injecting and injecting body fluid leakage preventing agent into the throat portion from the above-mentioned nostril, and injecting it. The device for the treatment of body fluid leakage prevention agent in the anus and/or vagina and the prevention of leakage of body fluid from the ear hole and/or the nostril -15- 200913976 The fiber sealing material is also closed by the fiber which is more suitable for the mouth. The material is preferably a composition of a body treatment kit having all the necessary processing tools in the container, so that the carrying is simple and the body can be disposed more quickly. In addition, it also has a fiber-made sealing material for preventing leakage of body fluids from the ear holes and/or nostrils, or a fiber-made sealing material for gargle in the mouth, and can more reliably prevent muscle relaxation of various parts of the body cavity after death. leakage. BEST MODE FOR CARRYING OUT THE INVENTION The inventors of the present invention have found that the results of efforts to solve the above-mentioned conventional problems are found to be rapid when mixed with water containing a group selected from polyethylene glycol and a nonionic surfactant. a liquid-like base material (A) soluble in water, and a viscous liquid base dissolved in the above-mentioned specific dispersion stabilizer (B), and dispersed in a gel form of the superabsorbent resin powder (C) When the body fluid leakage preventing agent is in contact with the body fluid, the liquid-absorbing substrate (A) is heated to increase the liquid absorption speed of the superabsorbent resin powder (C), and the body fluid is quickly absorbed and swollen to be solidified into no fluidity. The solid gel is in the form of a complete one. In other words, since the water absorption speed of the general superabsorbent resin powder (C) tends to be higher as the temperature is higher, the above-mentioned high is increased by the heat generation of the liquid substrate (A) when it comes into contact with the body fluid. The liquid-absorbent speed of the water-absorbent resin powder (C) rapidly absorbs body fluids and swells, and solidifies into a solid gel form which is fluid-free. However, since the higher the liquid absorption speed, the surface portion of the gelled substance which is in contact with the body fluid rapidly solidifies into a solid gel having no fluidity, the uniform dispersion of the superabsorbent resin powder (C) is easy. Crash-16- 200913976. Therefore, in the body fluid leakage preventing agent of the present invention, the above-mentioned specific dispersion stabilizer (B) which is capable of absorbing various aqueous electrolyte solutions and which is hardly affected by the electrolyte concentration is further dissolved in the viscous liquid base, and the superabsorbent resin powder is retained ( C) Uniform dispersion. Therefore, when the body fluid leakage preventing agent of the present invention is injected and attached to the body cavity of the body by the injection device, the body fluid is absorbed and swollen, and the solid body gel is solidified into a fluid-free solid state, thereby effectively preventing the body fluid. leakage. The substrate (A) which is heated at room temperature when mixed with water is polyethylene glycol (having a polymerization degree average molecular weight of 600 or less) or a nonionic surfactant, and may be, for example, a coconut. Oil fatty acid monoethanol decylamine, coconut oil fatty acid diethanol amide 1 : 1, coconut oil fatty acid diethanol amide 1 : 2, polyethylene oxide coconut oil fatty acid monoethanol decylamine, lauric acid diethanol amide , polyethylene oxide lauryl ether, polyethylene oxide cetyl ether, polyethylene oxide higher alcohol ether, polyethylene oxide polypropylene oxide ethylene glycol (addition of ethylene oxide to polypropylene glycol) Pluronic type nonionic surfactant), polyethylene oxide alkyl (alkyl group has 12 to 14 carbon atoms) ether (ethylene oxide addition molar number: 7 to 12 moles), etc. The surfactants such as a polyethylene oxide alkyl ether system, a sorbitan fatty acid ester type, and a polyethylene oxide sorbitan fatty acid ester type may be used alone or in combination of two or more. In the liquid substrate (A), liquid polyethylene glycol (having an average molecular weight of about 200 to 600) is preferred. In the liquid substrate (A), especially the liquid polyethylene glycol (the average molecular weight of the polymerization degree is about 200 to 600) is at a low temperature (about 30 ° C to 50 ° C) and can be easily dissolved. Dispersion stabilizer (B), especially polyepoxide-based heat -17-200913976 plastic non-ionic water-absorbent resin powder, when mixed with water, as shown in Test Examples 1 and 3 to be described later, heat when exposed to water The water temperature rises (increased by 10 °C to 1 2 °c), and since it is a surfactant, it has good compatibility with water, and is easily mixed and dissolved with water, and the superabsorbent resin is improved as described above. The rate of water absorption is rapidly solidified into a solid gel with no fluidity to prevent leakage of body fluids. The content of the liquid substrate (A) is preferably about 10 to 85% by mass based on the total amount of the body fluid leakage preventing agent, and is preferably about 2 〇 to 80% by mass, and more preferably about 30 to 70% by mass. better. When the content of the liquid substrate (A) is more than 85 mass%, the problem of dispersibility of the superabsorbent resin powder is not obtained, but since it is difficult to form a gel, the state of the liquid is close to the solution', so suitable. On the other hand, when the content of the liquid substrate (A) is too low, it is difficult to form a good gel state, which is not preferable. The body fluid leakage preventing agent of the present invention may contain an anionic surfactant in addition to the above liquid substrate (A) in a ratio which does not impair the efficacy of the present invention. Examples of the anionic surfactant include polyethylene oxide alkyl ether sulfate, polyethylene oxide sodium lauryl ether sulfate, polyethylene oxide lauryl ether sulfate triethanolamine, and polyethylene oxide. Alkyl group (the number of carbon atoms of the alkyl group is 11 to 15) sodium ether sulfate (addition of molar number of ethylene oxide: 3), alkyl group (carbon number of alkyl group is 11, 13, 15) triethanolamine , alkyl alkyl sulfate, alkylethanol sulfate triethanolamine, higher alcohol sodium sulfate, etc. alkyl ether sulfuric acid; polyoxyethylene alkyl sulfosuccinate disodium, polyethylene oxide sulfosuccinic acid, polycyclic Oxyethane sulfosuccinate disodium lauryl disodium, sulfonic acid lauryl disodium, sulfo amber-18- 200913976 acid polyethylene oxide lauryl ethanol decylamine disodium sulfosuccinate; A surfactant such as an alkylbenzenesulfonic acid group such as sodium alkylbenzenesulfonate may be used alone or in combination of two or more. The dispersion stabilizer (B) used in the present invention is used to maintain a uniform dispersion state of the superabsorbent resin powder, and at least one polyepoxide selected from the group consisting of an aqueous solution which can absorb various electrolytes and is hardly affected by the electrolyte concentration can be used. Thermoplastic non-ionic water-absorbent resin, carboxyvinyl polymer of acrylic polymer, alkali salt of carboxyvinyl polymer of acrylic polymer, lipophilic smectite, synthetic hectorite, natural lithium montmorillon Stones and bentonites are grouped together. Among these dispersion stabilizers (B), it is preferred to use a polyepoxide-based thermoplastic nonionic water-absorbent resin which can absorb various aqueous electrolyte solutions and is hardly affected by the electrolyte concentration, and can absorb an acid or a base. Aqueous solution. The content of the dispersion stabilizer (B) is about 0% of the total amount of the body fluid leakage preventing agent. 5 to 40% by mass is preferably, preferably about 1 to 30% by mass. When the content of the dispersion stabilizer (B) is too low, it is difficult to maintain the uniform dispersibility of the superabsorbent resin powder, and on the other hand, even if it is more than 40% by mass, it does not have the above improvement effect. Economically not appropriate. As the superabsorbent resin powder (C) used in the present invention, a powder of various conventionally known superabsorbent resins can be used, but it is not limited to a specific one, and at least one polyethylene acrylate selected from the above may be suitably used. , polyacrylate, alginate, acrylic graft copolymer crosslinker, copolymer of vinyl alcohol and polyacrylic acid, polyethylene glycol polymer, polypropylene amide resin, copolymerization of polyacrylic acid and maleic acid The compound, the polyethylene oxide polymer -19-200913976, and the polyalginate polymer are grouped. The above superabsorbent resin powder (C) is preferably a powder having an average particle size of about 18 to 1 60 mesh (indicated by Tyler), and preferably about 30 mesh to 140 mesh. Further, the content of the superabsorbent resin powder (C) is such that the body fluid in the body does not leak out of the body cavity, and is immediately absorbed and expanded to form a necessary amount of the gel having no fluidity. The content of the superabsorbent resin powder is preferably from about 5 to 50% by mass based on the total amount of the body fluid leakage preventing agent, and particularly preferably from about 15 to 35 mass%. The body fluid leakage preventing agent of the present invention, in addition to the above components, may also contain a water-soluble alcohol-based organic solvent (D) as a co-solvent or a tackifier for improving fluidity (E). ). As the alcohol-based organic solvent (D), a solvent soluble in water of the above liquid substrate or a polar solvent can be used, and it is not particularly limited, and at least one selected from the group consisting of ethylene glycol, propylene glycol, and diethyl ether can be suitably used. An alcohol-based organic solvent in which diol, triethylene glycol, glycerin, methanol, ethanol, and isopropyl alcohol are grouped. Among these alcohol-based organic solvents, glycerin is preferred. Glycerin is easily mixed with water, although it is only a small amount, but the water temperature rises slightly when it is mixed (about 3 t). Therefore, it can help increase the water absorption speed of the superabsorbent resin, and improve the viscosity of the prepared body fluid leakage preventing agent, so that the fluidity is good, and at the low temperature, it helps to prevent the gel from solidifying. The content of the alcohol-based organic solvent is preferably from about 3 to 50% by mass based on the total amount of the body fluid leakage preventing agent, and is preferably from about 5 to 30% by mass. The tackifier (E) is not particularly limited, and at least one selected from the group consisting of sodium carboxymethylcellulose, carboxymethylcellulose, methylcellulose-20-200913976, polyvinyl alcohol, and poly A viscosity-increasing agent of vinylpyrrolidone, sola gum, and sodium alginate. The content of the tackifier is about 0% of the total amount of the body fluid leakage preventing agent. 5 to 30% by mass is preferably, preferably about 1 to 20% by mass. The body fluid leakage preventing agent of the present invention may further contain at least one other additive selected from the group consisting of a bactericide, a mold, a preservative, a deodorant, and a fragrance, as needed. Examples of the bactericide include isopropylmethyl phenol, chlorhexidine gluconate, thymol, o-phenylphenol, alkyl dimethyl benzyl chloride, and hexagram-based chlorinated paper. (Cetylpyridinium chloride), Benzethonium chloride, Triclosan, ε-polylysine, LySOZyme chloride, eucalyptus, grapefruit seed extract The extract r Wasaouro" or the like may be used alone or in combination of two or more. As a mildew. The preservative may, for example, be sodium p-hydroxybenzoate, butyl p-hydroxybenzoate, propyl p-hydroxybenzoate, isobutyl p-hydroxybenzoate, sodium benzoate, sodium propionate, Thiabendazole, isothiaporphyrin. The ketone (Isothiazolone) or the like can be used singly or in combination of two or more. As the deodorant, for example, Meng Zongzhu extract, green tea extract, long-chain betaine compound, persimmon extract, the general name of tannin as a main component deodorant, and plant extracts mixed with a special deodorant These may be used alone or in combination of two or more. Further, as the fragrance, various natural and artificial flavors such as floral notes, citrus notes, fruity notes S, woody g weeks, fresh note, mixed notes, grassy notes, and mint notes may be mentioned. -21 - 200913976 Such as the above-mentioned fungicide, anti-mildew. The content of preservatives, deodorants and perfumes' maintains the desired effect of each component, and the ratio of the total body fluid leakage preventive agent having viscosity and fluidity is obtained from the viewpoint of safety and good economy. And the anti-mold preservative is preferably about 0. 0 0 1~1 5 mass% respectively. 003~8 mass% is especially good. Similarly, the deodorant is about 0. 05~20% by mass is suitable, about 0. 1 to 10% by mass is especially preferred. In addition, the fragrance is about 0. 001~1〇% by mass is suitable, about 0. 01~5 quality % is especially good. Others may contain a coloring matter, and the amount of the compounding amount and the color tone are not particularly limited, and may be arbitrarily set. The viscosity of the body fluid leakage preventing agent of the present invention containing the above components is preferably from about 6,000 to 50,000 cPs, preferably from about 10,000 to 40,000 Å. In addition, the viscosity system is a viscosity meter ("Viscometer" type: DV-1 +, manufactured by Brookfield, USA), and a motor shaft (Spindle) No. 07, the number of rotations: 20 rpm, and the temperature of the body fluid leakage preventing agent is measured at a temperature of 20 ° C. However, the measurement is not limited thereto, and the measurement may be carried out under the same conditions. In addition, since the content of the above solvent (A) is lower, the higher the content of the superabsorbent resin powder (C), the shorter the time during which the body fluid leakage preventing agent becomes gelatinous, and the higher the viscosity of the liquid, The amount of the compounding is adjusted to adjust the liquid viscosity in response to the time required to form a gel or the intended use (application site). The amount of the body fluid leakage preventing agent to be injected into the body cavity to be injected into the body cavity can be appropriately set depending on the site to be applied, and is not particularly limited. In addition, 'the water absorption property of the superabsorbent resin contained in the gel-like body fluid leakage preventive agent is ''has a gelatinous shape of 3,000 ml of water to prevent the body fluid from leaking out of the body cavity. The degree can be generally 5 to 60 g, preferably 10 to 40 g. For example, the amount of the body fluid leakage preventing agent (containing 5 to 50% by mass of the highly water-absorbent resin) to be injected into the throat portion of the body is preferably about 8 to 40 g, more preferably 10 to 25 g. When the injection amount of the gel-like body fluid leakage preventing agent is too large, since the injection device becomes large, it is difficult to handle and the cost becomes high. On the other hand, when the amount of the injection is too small, it is difficult for the body fluid to solidify into a gel form, and there is a risk that the body fluid leaks out, which is not preferable. [Embodiment] Embodiments Hereinafter, specific examples of various types of the body treatment apparatus according to the present invention will be described with reference to the accompanying drawings. 2 to FIG. 5 show a treatment device for inserting and mounting the body fluid leakage preventing agent into the throat portion from the nostril, and FIGS. 2 to 4 show the injector 1 and FIG. 5 shows the insertion tube 40. The symbol X indicates the body fluid leakage preventing agent of the present invention accommodated in the injector 10. Fig. 2 to Fig. 4 show the injector 10'. Fig. 4 is a cross-sectional view showing a state in which the state shown in Fig. 2 is rotated by 90° around the center line. As shown in Fig. 2 to Fig. 4, the injector 10 is composed of a cylindrical body 20 and a piston 30 which are made of plastic such as high-density polyethylene, polyester or polyamide. The cylindrical body 20 is formed of a cylindrical member 21 having a discharge cylinder portion 22 that operates as a discharge port portion at the tip end, and a cover member 25 that covers the periphery. -23- 200913976 As shown in Fig. 2, the covering member 25 is a cylindrical body having an octagonal cross section, which can be easily discriminated by a nurse in a hospital without erroneously thinking that the general syringe is constructed, and the tip end portion is formed into a fine front end. It has a conical shape and is not easily peeled off when the cylindrical member 21 is fitted. Further, by coloring the covering member or coloring the color to be different from the color of the other members to form a color injector, the application site can be clearly grasped. As is apparent from Fig. 4, the covering member 25 is attached to the rear end portion with a pair of flange portions 26 projecting from the fingers in the radial direction. The tip end portion of the flange portion 26 is bent in the direction of the discharge cylinder portion 22, and the fingers will be easily caught. Further, a pair of convex stop portions 23 are formed at the rear end of the cylindrical member 21, and the flange portion 26 is brought into contact with the stop portion 23, and the finger hooks the flange portion 26 for the injection operation. The covering member 25 does not move to the rear of the rear end of the cylindrical member 2 1 . Further, the opening end portion of the discharge cylinder portion 22 is attached to the protective cover 209 which is filled in the injector 10 after the body fluid leakage preventing agent of the present invention is filled. Further, in the present embodiment, the cylindrical member 21 and the covering member 25 are individually formed, but they may be integrally formed. Further, the cylindrical member 21 and the covering member 25 may be bonded by an adhesive or may be formed at a contact portion of the tip end portion, and one member may be formed into a hole portion, and the other member may be formed into a claw portion in which the hole portion is fitted. , and so on, and fixed each other. On the other hand, the piston 30 is slidably inserted from the rear end portion side of the cylindrical member 2 1 of the cylindrical body 20. The length of the piston 30 is a body fluid leakage preventing agent X which can press out the entire contents, and is designed to be longer than the length of the cylindrical member 21. The piston 30 has a piston rod 31 having a cross-shaped cross section, and the tip end portion is formed into a circle-32-200913976-shaped flange portion 32 having a diameter slightly larger than the cross-sectional dimension of the piston rod. The rubber flange 34 made of synthetic resin, rubber or the like is crowned from the round flange portion 32 so as to protrude around the flange portion 33 formed. At the rear end of the piston rod 3 1 , the finger is easily pushed against the piston rod 3 1 to form a disc-shaped portion 35 which contacts the finger. When the piston 30 is inserted into the cylindrical member 21 of the tubular body 20 from the rear end side, the rubber pad 34 is in contact with the inner peripheral surface of the cylindrical member 2 1 of the injector 10, and is slid in a cylindrical shape. The composition of the member 2 1 . Further, the inner peripheral surface in the vicinity of the rear end portion of the cylindrical member 2 1 forms an annular projecting strip portion 24 which slightly protrudes inwardly, so that the circular flange portion 32 of the piston rod 31 contacts the protruding strip. The portion 24 is configured such that the piston 30 is less likely to be pulled out from the tubular body 20. Further, in the present embodiment, the piston rod 3 1 has a cross-shaped cross section, but may have a rod shape having a circular cross section or the like. When the insertion tube 40 is inserted into the nostril, it is made of a flexible resin such as a polyester elastomer, a soft chlorinated vinyl resin or a rubber which has flexibility and flexibility along the shape of the nasal cavity. As shown in FIG. 5, the insertion tube 40 is formed by inserting the tube body 40a and the connecting portion 43, and the tip end portion 41 of the insertion tube body 40a is made to be easily inserted from the nostril to form a hemispherical shape and closed. The two sides of the side, which are staggered in position, have a pair of opening portions 42 in the direction of the straight line, and at the rear end portion, the discharge tube portion 22 for connecting the injector 1 is slightly expanded on the rear side. Conical connecting portion 43. Further, the predetermined distance from the rear end of the insertion tube 40 (preferably at the tip end position of the connecting portion 4 3) is a stopper portion 44 having a convex cross section which is protruded from the outer periphery in the radial direction. The diameter of the restraining portion 44 must be such that it cannot be inserted into a desired body cavity such as a nasal hole. The opening portion 42 of the tip end portion of the insertion tube 40 can form a hole of a desired shape such as a circular shape of -25-200913976, an elliptical shape or the like, and the position is preferably about 5 to 30 mm from the tip end of the insertion tube. Further, the number of the opening portions 42 is four in this embodiment, but may be any number from 1 to 6. Further, the stopper portion 44 is determined by the length (injection position) of the opening portion 42 when the insertion tube body 40a is inserted through the nostril into the pharyngeal portion, from the tip end of the insertion tube 40 to the length of the stopper portion 44. Preferably, it is about 100 to 140 mm, and the insertion tube body 40a has an outer diameter of about 3. 5~7mm, the inner diameter is about 2~5mm. Further, in the above embodiment, the rear end portion of the insertion tube 40 is integrally formed with the connecting portion 43, but the connecting portion 43 may be individually. In this case, the connecting portion is preferably formed of a rigid synthetic resin, and the connecting portion is bonded to the insertion tube system by a suitable means such as a bonding agent or welding. Alternatively, the restraining portion 44 may be formed at the tip end of the connecting portion or may be formed at the rear end of the insertion tube. Alternatively, the insertion tube body may be bent from a predetermined position of the apex portion, and the insertion into the pharyngeal portion from the nostril may be smoothly inserted without resistance. When the above-described body treatment device is used, first, the protective cover 29 of the discharge cylinder portion 22 of the injector 10 is removed, and the connection portion 43 of the discharge tube portion 22 is inserted into the insertion tube 40, and the insertion tube 40 and the injector 10 are connected. . Next, the insertion tube body 40a is inserted from the nostril A (refer to Fig. 1) toward the throat portion B, and the insertion is stopped when the restraining portion 44 of the insertion tube 40 contacts the tip of the nose. At this time, in order to reduce the insertion resistance, the lubricant may be applied to the insertion tube body 40a. Next, the piston 30' of the injector 10 is pushed so that the gel-like body fluid in the injector 10 leaks out of the inhibitor X into the throat portion B via the insertion tube 40. The -26-200913976 body fluid leakage preventing agent X in the injector 10 is pushed out, and after the filling, the injector 10 and the insertion tube 40 are pulled out from the nostril A. Further, in the above-described operation method, the insertion tube 40 is inserted into the nostril A in a state where the insertion tube 40 is connected, but the insertion tube 40 may be inserted into the nostril A first, and then the injector 10 may be connected to the insertion tube 40. Further, the injector 10 and the insertion tube 40 are housed in a container in a state in which they can be connected, and at this time, they can be taken out from the container and immediately processed. Alternatively, the implanter 10 may be separate from the insert tube 40 in the above embodiment, but these may be made in one piece. Further, even if the stopper portion 44' formed by replacing the insertion tube 40 is marked, it is possible to prevent the insertion position from being uneven to some extent. Next, a suitable embodiment of the treatment device for injecting and dissolving the body fluid leakage preventing agent in the anus and/or the vagina will be described with reference to FIGS. 6 to 8 . FIG. 6 to FIG. 8 show the injector 10a. A cross-sectional view showing a state in which the state shown in Fig. 6 is rotated by 90 ° around the center line. As shown in FIG. 6 to FIG. 8 , in the embodiment, as in the above embodiment, the injector 10a is made of plastics such as high-density polyethylene, polyester, polyamide, and the like. The tubular body 20a and the piston 30 are formed. However, in the injector 10a, the fibrous filling material (plug material) γ is accommodated together with the gel-like body fluid leakage preventing agent X. The fibrous filling material Y is in the body cavity of the anus or the vagina, and the gel-like body fluid leakage preventing agent X becomes a solid gel, 'even if the muscles of various parts of the body cavity are relaxed after the death, and the solid gel If a void occurs, it can still be used to prevent leakage of bodily fluids. However, the storage may also only leak gel-like body fluids. The amount of the body fluid leakage preventing agent χ (containing 5 to 5% by mass of the super absorbent resin) contained in one device is preferably about 1 to 10 g, preferably about 1 to 5 g, and the length of the fibrous filling material Y is It is suitable to set it to about i 〇~3 〇mm and the diameter is about 8~23mm. The cylindrical body 20a is formed by a cylindrical member 21a having a discharge port portion 22a at the tip end and a cover member 25a covering the periphery. The discharge port portion 22a of the cylindrical member 2 1 a is bent toward the center toward the center in the radial direction, and is formed into a hemispherical shape by a plurality of tongues 28 existing along the line, and by the majority of the tongues 28 The opening of the tip end portion and the gap between the tongue pieces form an opening portion. Each tongue piece 28 has a softness that can be bent outward. In addition, after the death to the stiffness, when a large-sized cylindrical syringe (Syringe) is inserted into the anus or the vagina, the anal canal or the vaginal opening is enlarged, and it takes time to contract, so it becomes a cause of leakage of body fluid. Further, the cylindrical member 2 1 a has a small outer diameter and is easy to insert. Therefore, it is preferable that the outer diameter of the cylindrical member 2 1 a is about 10 to 25 mm, preferably about 10 to 15 m m , and the inner diameter is about 8 to 23 mm. The covering member 2 5 a is a cylindrical body having an octagonal cross section as shown in Fig. 6. It is a hospital nurse who can easily distinguish it from a general syringe. Further, by coloring the cover member or coloring the color to make it different from the color of the other members to form a color injector, the application site can be clearly grasped. As is apparent from Fig. 8, at the rear end portion of the cylindrical member 2 1 a, a pair of flange portions 2 6 which are protruded from the finger and protruded outward in the radial direction are provided. On the other hand, the covering member 25a is attached to The tip end portion has an umbrella-shaped stopper portion 27 that is deployed rearward. It is preferable that the distance from the tip end of the cylindrical member 2 la to the stop portion 27 is set to be in the range of about 15 to 50 mm, and the height of the peripheral portion 27 from the outer peripheral surface of the cylindrical member 2 1 a is preferably set. It is preferably set within a range of about 5 to 30 mm which is easy to stop at the anus or vaginal opening. In addition, the restraining portion 27 does not necessarily have an umbrella shape as in the present embodiment, as long as it can be ensured that only the insertion position of the injector 10 in the length of the anus or the vagina is inserted, and no more than the above members or marks are used. For example, it may be in the shape of a disk, or it may be visually identifiable. Further, the tip end portion of the flange portion 26 is bent in the direction of the discharge cylinder portion 2 2 a, and the fingers are easily caught. The height of the flange portion 26 from the outer peripheral surface of the cylindrical member 21a is about 5 to 18 mm. The degree of bending of the tip end portion is preferably set within a range of 0 to 50 °. In addition, when the covering member is used, the flange portion and the stopping portion may be disposed at a predetermined position of the covering member, but in the embodiment, the stopping portion is disposed at the tip end portion or the covering member of the covering member. When the cylindrical member has the same length, the approximate intermediate portion 'the flange portion is preferably provided at the rear end portion of the cylindrical member. Further, the 'cylindrical member 2 1 a rear end is formed to be connected to the above-mentioned pair of flange portions 26 6 ' protruding from the side to the convex stop portion 2 3 a, and the covering member 2 5 a is configured by When the contact portion 2 3 a and the flange portion 2 6 ' are pressed against the flange portion 26 to perform the injection operation, the covering member 25a does not move to the rear end of the cylindrical member 21a. Further, the protective cap 29a is removed from the tip end portion of the cylindrical member 2 1 a after the body fluid leakage preventing agent of the present invention is filled in the injector 10. Further, in the present embodiment, the 'cylindrical member 2 1 a and the covering member 2 5 a are formed separately, but they may be integrally formed. -29-200913976 On the other hand, the structure of the piston 30 is the same as that of the above-described embodiment, and is slidably inserted into the cylindrical member 21a of the cylindrical body 20a from the rear end portion side. In order to cause the body fluid leakage preventing agent X and the fiber filling material Y to be pushed out of the entire contents, the length of the piston 30 is designed to be longer than the length of the cylindrical member 2 1 a. The piston 30 has a piston rod 31 having a cross-shaped cross section, and the leading end portion is formed into a circular flange portion 32 having a diameter slightly larger than the sectional size of the piston rod. The rubber flange 34 made of synthetic resin or rubber is crowned from the circular flange portion 32 to protrude around the flange portion 33 formed. Further, at the rear end of the piston rod 31, in order to make the finger easily push the piston rod 31, a disc-shaped portion 35 which contacts the finger is formed. When the piston 30 is inserted into the cylindrical member 21a of the cylindrical body 20 from the side of the rear end portion, the rubber pad 34 is in contact with the inner peripheral surface of the cylindrical member 2 1 a of the injector 10, and is slid in a circle. The cylindrical member 2 1 a is inside. Further, the inner peripheral surface in the vicinity of the rear end portion of the cylindrical member 2 1 a is formed with an annular projecting strip portion 24 which slightly protrudes inwardly, by contacting the circular flange portion 32 of the piston rod 31 The protruding strip portion 24 constitutes that the piston 30 is not easily pulled out from the cylindrical body 20. Further, in the present embodiment, the piston rod 3 1 has a cross section in cross section, but may have a rod shape having a circular cross section or the like. When the above-mentioned anal and/or vaginal treatment device is injected and mounted, the protective cover 29a of the discharge port portion 22a of the injector 10a is not removed. Insert directly into the anus or vagina, for example, and stop the insertion when the part 27 contacts the outside of the anus or vagina. At this time, in order to reduce the insertion resistance, a lubricant may be applied to the protective cover 29a. Next, the piston 30 of the injector i〇a is pushed, and the gel-like body fluid leakage preventing agent X and the fiber filling material Y injected into the injector 10a when the protective cover 29a is the same as -30-200913976. At this time, the superabsorbent resin powder in the body fluid leakage preventing agent X which absorbs the body fluid and the liquid in the soil is swollen, and the portion penetrates into the fiber-filled material Y, and the solid gel is formed, so that the body can be effectively prevented. And dirt leaked out. Thereafter, the injector 10a is withdrawn from the anus or vagina. In addition to the gel-like body fluid leakage preventing agent containing the superabsorbent resin powder, the body fluid leakage preventing agent X may be a highly water-absorbent resin powder or a compression-molded product, a super absorbent resin powder, or a fiber. The filling material is compressed together with the plasticizer. As the gel-like body fluid leakage preventing agent, various kinds of body fluid leakage preventing agents which are conventionally known in the form of a gel can be used, but it is preferable to use the above-mentioned gel-like body fluid leakage preventing agent according to the present invention. The body fluid leakage preventing material contains or retains the highly water-absorptive resin powder because the superabsorbent resin powder that absorbs the liquid in the body fluid and the liquid is swollen (when the water-absorbent fibrous filler material is used, the portion penetrates into the water-absorbent fibrous charge) Since the ruthenium material is a solid gel, it is possible to reliably prevent leakage of body fluids and dirt. On the other hand, the fibrous filler material Y is a molded product of a non-absorbent resin fiber, a compressed pulp paper, a cotton, a cotton, a super absorbent resin fiber, a super absorbent resin fiber, or a synthetic fiber. Non-woven fabric, cloth, etc., but in particular, LANSEAL (registered trademark) F or LANSEAL (registered by Toyobo Co., Ltd.) made of water-swellable fiber, for example, an inner layer of acrylic fiber and an outer layer formed of water-absorbent resin The trademark K is preferably formed into a cylindrical shape, or a compression molded pulp is formed into a cylindrical shape (for example, a tampon type for women). In addition, it is also possible to form a variety of fibers from -31 to 200913976 into a spherical shape. For example, when a compression-molded body containing a superabsorbent resin powder or a gel-like body fluid leakage preventing agent X' which is rapidly expanded to form a solid gel and a water-absorbent fibrous filler material γ are used in combination, the injector is used. In the inside of the cylindrical body, a compression-molding body containing a superabsorbent resin powder, a gel-like body fluid leakage preventing agent, and a water-absorbent fibrous filling material are sequentially housed from the discharge outlet side, and a discharge port of the cylindrical body tip end is attached. It is freely closed by the sealing material. According to this configuration, the compression-molding body containing the superabsorbent resin powder or the gel-like body fluid leakage preventing agent and the water-absorbent fibrous filler material can be directly injected and attached to the body cavity without removing the sealing material. Therefore, the workability is good, and the anus or vaginal sealing of the remains is carried out easily and hygienically. In addition, at this time, the superabsorbent resin powder in the body fluid leakage preventing material that absorbs the body fluid and the liquid in the dirt is swollen, and the portion penetrates into the water-absorbent fibrous filler material to become a solid gel. It is sure to prevent body fluids and dirt from leaking out. Further, in the above-described embodiment, the discharge port portion 22a at the tip end of the cylindrical member 21a is bent toward the center in the radial direction, and is formed into a hemispherical shape by a plurality of tongues 28 existing along the line, but the cylinder The discharge port at the tip end of the member may be a circular shape such as an end surface of the cut cylindrical body. At this time, the tip end portion of the cutting cylinder must be closed by a protective cover (closing member). As a protective cover (closed member), in addition to the approximately hemispherical dome-shaped pattern as shown in FIGS. 7 and 8 above, it may be embedded in a disc shape or in a tip end portion of the cut cylindrical body. a circular plate-shaped inner cover for blocking the shape of the dome-shaped cover member from the top to the tip end portion, using a hemispherical portion having a diameter larger than the inner diameter of the circle -32-200913976, and having The round bar portion having the same diameter as the inner diameter of the cylindrical body becomes an integral mushroom-shaped protective cover (closed member), and the round bar portion is embedded in the apex of the cylindrical body to block the shape of the spout and is embedded. A protective cover (closed member) having a hemispherical portion having a diameter equal to the inner diameter of the cylindrical body and a shape integral with the round bar portion at a tip end of the cylindrical body to block the discharge port. As the material of the protective cover (closing member), a solid soap made of tallow, coconut oil, palm oil or the like, or polyethylene glycol (PEG, a solid matter having an average molecular weight of about 100 or more) can be used. Plastic materials, especially polyethylene (PE), polypropylene (PP), polyamide (PA, alias: nylon) and other thermoplastic plastic, rubber, super absorbent resin fiber moldings, compression molding pulp into a cylindrical shape (Example: tampon type for women), cotton and super absorbent resin fiber blend, synthetic fiber or natural fiber molded non-woven fabric, plastic foam (independent bubble foam), wood, cork, etc. Such as the above-mentioned treatment from the nostril, the treatment device for injecting and squeezing the body fluid leakage preventing agent in the throat portion, and the treatment device for injecting and squeezing the body fluid leakage preventing agent into the anus and/or the vagina, and preventing the self-ear hole and/or Or the fibrous sealing material for leaking body fluids in the nostrils or the fibrous sealing material for the other in the mouth is stored in a container, and it is suitable for the body processing device unit, so that it is convenient to carry and can be quickly processed. The fiber-made sealing material for preventing leakage of body fluid from the ear hole and/or the nostril can be suitably formed by blending and non-woven fabric of cotton, super absorbent resin fiber, cotton and super absorbent resin fiber to form a spherical or columnar shape. The shape of the cube, etc. For the earplugs with 2 and the nasal plug with 2 seals -33- 200913976 closed material is appropriate. In addition, the fibrous sealing material for the mouth is placed in the cheek to prevent leakage of bodily fluids and to form a cheek swelling similar to natural swelling. It is suitable for use with cotton, cotton and super absorbent resin fibers as described above. a cloth or a non-woven fabric of a blended, high-absorbent resin fiber, or a non-woven fabric material of cotton or a highly absorbent resin fiber, or a material in which the single-layer material is laminated into a sandwich-like material in an arbitrary layer structure A sealing material formed. Fig. 9 is a view showing a modification of the tip end portion of the insertion tube for injecting body fluid leakage preventing agent of the present invention. In this modification, as shown in FIG. 9, the tip end portion of the insertion tube main body 40a is formed into a hemispherical shape by a plurality of tongue pieces 45 which are bent outward toward the center in the radial direction, and the majority of the tongue pieces 45 are formed. The opening formed by the tip end and the opening formed by the gap between the tongues are formed. Each of the tongue pieces 45 has flexibility to be bendable to the outside. Therefore, when the body fluid leakage preventing agent filled in the injector is pushed out by the piston, the body fluid leakage preventing agent is pushed out by the majority of the tongue pieces, and since the gap between the self-expanded tongue pieces is also pressed out, the surface area is increased. Become bigger. Fig. 1 shows another embodiment of the insertion tube for injecting body fluid leakage preventing agent according to the present invention. In this embodiment, the insertion tube is the same as the insertion tube shown in Fig. 5 except that the insertion tube body 40a is bent from the predetermined position of the tip end portion. By forming such a curved portion 46, it can be smoothly inserted without any resistance when the nostril is inserted deep into the pharyngeal portion. At this time, the bent position is about 22 to 45 mm from the tip end of the insertion tube main body 40a, and the distance is about 20 to 30 mm, preferably -34 to 200913976, and the bending angle is 0 to 95. Preferably, in the above embodiments, the end portion of the insertion tube body 40a and the connecting portion 43 are integrally formed, but the connecting portion 43 may be different individuals. 1 is shown. The insertion tube main body 40a is separately prepared in advance, and the recessed portion 48 formed at the tip end portion of the connecting portion 43 is inserted into the insertion tube main body 40a, and the end portion 47 is bonded by a suitable means such as adhesive, welding or the like. When the insertion tube main body 40a and the connecting portion 43 are individually formed as described above, the connecting portion 43 is preferably formed of a rigid synthetic resin. Further, in this embodiment, the stopper portion 44 may be formed at the tip end of the connecting portion 43. The above is a description of the various examples of the various types of the body treatment device of the present invention, but the gel-like body fluid leakage prevention agent of the present invention can also be injected and attached to the body of the body by a conventionally known injector. The body cavity of the nose, the ear, the anus, the vagina of the woman, and the like, and the liquid is closed, of course, is not limited to the above various types. The following are examples and test examples in which the effects of the body fluid leakage preventing agent of the present invention are specifically confirmed. However, the present invention is of course not limited to the following examples. In addition, in the following, unless otherwise specified, "%" means "% by mass". Test Example 1 (Test for measuring the heat generation temperature of the test material) Test method and method: Each raw material shown in Table 1 of 10 g of the amount of the raw material was placed in a beaker of 3 ml, -35-200913976, and then the injection was measured under the following conditions. The heating temperature of the mixture when the ion exchange water of g. Detector: Liquid of DATA COLLECTOR made by Anlimeter (share). Temperature sensor. Room temperature at the time of measurement: 2 2. 3 t. The test results are shown in Table 1. Table 1 Raw material name Test times Initial material temperature (°C) Liquid temperature immediately after mixing rc) Liquid temperature after 90 seconds (°C) PEG200 1st time 23. 9 35. 0 31. 7 2nd time 25. 1 37. 8 33. 1 anhydrous glycerin 1st 24. 9 28. 0 26. 8 2nd time 25. 2 28. 5 27. 2 ethylene glycol first time 24. 7 27. 9 26. 9 2nd time 24. 7 28. 9 27. 0 Ethanol First time 24. 2 28. 0 26. 5 2nd time 24. 5 28. 2 26. 6 Preparation PEG200: Polyethylene glycol with an average molecular weight of 200 of polymerization degree as shown in Table 1 above. When liquid PEG200 is mixed, it immediately generates heat when mixed with water, is rapidly soluble in water, and can maintain the temperature to some extent. The time of the degree. On the other hand, in the case of anhydrous glycerin, ethylene glycol or ethanol of an alcohol solvent, it is only slightly heated after being mixed with water, and the temperature is relatively low, and the temperature cannot be maintained. From this, it is understood that the liquid PEG 200 is suitable for increasing the liquid absorption rate of the super absorbent resin, and rapidly solidifies into a solid gel form having no fluidity, and is most suitable as a liquid leakage prevention for preventing leakage of body fluids - 36 - 200913976 The base. Examples 1 to 3 and Comparative Examples 1 and 2 The mixing ratios shown in Table 2 were high in the liquid of the polyethylene glycol 200 in the solution of the polyethylene oxide-based thermoplastic non-ionic water-absorbent resin. The water-absorbent resin powder was uniformly dispersed to prepare a body fluid leakage preventing agent (Examples 1 to 3). Further, for comparison, the acrylic polymer (the alkali salt of the carboxyvinyl polymer) as a gelling agent is dissolved in a liquid of an alcohol solvent, and the superabsorbent resin powder is uniformly dispersed to prepare a body fluid. Leakage prevention agent (Comparative Examples 1 and 2). The water absorption speed and state of the body fluid leakage preventing agent thus prepared are compared by the test methods described below. Test Example 2 (Water absorption speed test of test sample) Test method: Weigh the test sample of lg, put it into a beaker of l〇〇ml, and then inject 80 ml of ion-exchanged water (2 (TC), measure all ion exchange The time when the water became gelatinous. The test results are shown in Table 2. -37- 200913976 Table 2 Test sample No. Example No. Comparative Example No. 1 2 3 1 2 PEG200 75% 80% 85% Ethylene glycol — _ _ 79. 4% 89. 4% carboxyvinyl polymer _ • _ 0. 2% 0. 2% triethanolamine 0. 4% 0. 4% superabsorbent resin powder 20% 15% 10% 20% 10% Thermoplastic nonionic water absorbing resin 5% 5% 5% Total 100% 100% 100% 100% 100% Result to gelatinous time ( second) <3 times average> 102 178 522 510 Unopened gel preparation carboxyvinyl polymer: product name "Hibiswaco*" and Wako Pure Chemical Industries, Ltd. Superabsorbent resin powder: trade name 1QUA-KEEP* Sumitomo Seiki Co., Ltd. Thermoplastic non-ionic water-absorbent resin: trade name ^AQUA-COKE" Sumitomo Seiki Co., Ltd. 1 registered trademark As shown in Table 2 above, even superabsorbent resin powder When the amount of addition was the same as 1% by mass, in Comparative Example 2 using ethylene glycol as a base, gelation could not be formed, and Example 3 in which liquid PEG 200 was used in the opposite direction could form a gel. Further, in Comparative Example 2, it took 55 minutes for the superabsorbent resin powder to be uniformly dispersed, and the liquid state was a dilute aqueous solution. From this, it is understood that when an alcohol-based base is used, it takes a long time to prepare a body fluid leakage preventive agent, and workability is poor. In addition, even when the amount of the superabsorbent resin powder added was 20% by mass or less, in the case of Comparative Example 1 using ethylene glycol as a base, the gelation time was as long as 510 seconds, and PEG2 00 was used relatively. Example 1 was gel-formed in 102 seconds. From this, it is understood that the body fluid leakage preventing agent of the present invention is rapidly solidified into a non-flowing solid coagulation-38-200913976 gel, and is most suitable as a body fluid leakage preventing agent for preventing leakage of body fluid. Test Example 3 (Test for measuring the heat generation temperature of the test material) Test method: Each of the raw materials shown in Table 3 of 20 g was weighed and placed in a 50 ml beaker, and then a mixed solution of 16 g of ion-exchanged water was measured under the following conditions. The heating temperature. Tester: alcohol bar thermometer (temperature range is 〇~50 °C). Room temperature at the time of measurement: 1 8.5 °C. The temperature of the ion exchange water: 1 8.0 °C. The test results are shown in Table 3. Table 3 Raw material name (product name) Number of test initial material temperature (°C) Liquid temperature after mixing for 30 seconds rc) Liquid temperature after mixing for 60 seconds 液 Liquid temperature after mixing for 120 seconds CC) SANNONIC SS-120 1st 18.0 27.1 28.3 27.0 2nd 18.0 27.5 28.7 27.3 SANNONIC FN-100 1st 18.0 27.5 28.0 27.2 2nd 18.0 26.8 27.9 27.0 SORGEN TW-60V 1st 18.0 25.1 25.8 25.6 2nd 18.0 25.5 26.2 25.8 Preparation for SANNONIC SS -120 : Polyethylene oxide alkyl ether Sanyo Chemical Industry Co., Ltd. Non-ionic surfactant commercially available under the trade name SANNONIC FN-100: Polyoxyalkylene alkyl ether Sanyo Chemical Industry Co., Ltd. Nonionic interface activity The trade name of the agent is SORGEN TW-60V: Polyethylene oxide sorbitan monostearate The first industrial pharmaceutical (share) nonionic surfactant 〃 registered trademark -39- 200913976 as shown in Table 1 above When the nonionic surfactant is mixed with water, it immediately heats up. The mixing ratio of the nonionic surfactant to water in the above test, although the mixed liquid became a relatively viscous liquid', the nonionic surfactant was rapidly soluble in water. Thus, the "nonionic surfactant improves the water absorption speed of the superabsorbent resin" and rapidly solidifies into a solid gel having no fluidity, and is most suitable as a substrate for preventing a body fluid leakage preventing agent for preventing body fluid leakage. Example 4 to 7 SANNONIC SS-120 weighing 60 to 80 g in a beaker of 300 ml, placed on a hot plate, heated to 60 ° C to 80 t under stirring, and slowly added a dispersion stabilizer (5 g of polyepoxy) An ethane-based thermoplastic nonionic water-absorbent resin powder or another 1 g of polyethylene glycol) is dissolved in a viscous liquid, and then returned to room temperature, and slowly added (15 g to 25 g) of high water absorbability. The resin powder is used to prepare a gel-like body fluid leakage preventing agent. The water absorption speed and state of the body fluid leakage preventing agent thus prepared were compared in accordance with the same test method as in Test Example 2 (water absorption speed test of the test sample). The test results are shown in Table 4. -40- 200913976 Table 4 Test Samples Example No. 4 5 6 7 Prescription SANNONIC SS-120 70% 75% 80% 60% PEG#200 10% Thermoplastic Nonionic Water Absorbent Resin Powder 5% 5% 5% 5 % Superabsorbent resin powder 25% 20% 15% 25% Total 100% 100% 100% 100% Result to gelatinous time (seconds) <3 times average> 113 181 348 118 Preparation SANNONIC SS-120 (trade name): Polyethylene oxide compound ether Sanyo Chemical Industry Co., Ltd. Nonionic surfactant PEG#200 (trade name): Polyethylene glycol having an average molecular weight of 200, and a thermoplastic nonionic water-absorbent resin powder made from Nippon Oil & Fats Co., Ltd.: trade name "aqua-keep*" Sumitomo Seiki Co., Ltd. Superabsorbent resin powder: Product name ^AQUA-COKE*" Sumitomo Seiki Co., Ltd.* = Registered trademark As shown in Table 4 above, if the amount of superabsorbent resin powder is small, the water absorption rate becomes a solid gel. Slow down. In the above-mentioned Tables 2 and 4, it is shown that, in terms of water absorption speed, the gel-like body fluid leakage preventing agent having PEG #200 as the substrate of Example 1 has a fast time to become a fluid-free solid gel, and Appearance traits are also good. Therefore, as the substrate of the gel-like body fluid leakage preventing agent, polyethylene glycol is most suitable. Example 8 Weigh 68g of PEG #200 in a beaker of 300 ml, set on a hot plate, and heat to 6 after stirring (TC~80 °C, slowly add 7g of oleophilic-41 - 200913976 smectite) , after dissolving into a viscous liquid, 'recovering to room temperature', slowly adding 25 g of the super absorbent resin powder 'modulating the gel-like body fluid leakage preventing agent 〇 the water absorption speed and state of the body fluid leakage preventing agent thus prepared' The test method was the same as the test method of the above test example 2 (water absorption speed test of the test sample). The test results are shown in Table 5. Table 5 Test sample mass % One PEG #200 ... 68.00% _ Square lipophilicity Montmorillonite 7.00% Superabsorbent resin powder 25.00% Total 100.00% Time to gelation 89 Fruit (seconds) (3 times average) PEG#200 (trade name): The average molecular weight of polymerization degree is 200 The oleophobic montmorillonite made from the polyethylene glycol and the scorpion oils and fats: the product name "Rusentite SPNccl5", the CO-OPChemidal (supplement) super absorbent resin powder, the product name "aqua-keep*", Sumitomo Refined Co., Ltd. is a registered trademark as shown in Table 5 above. It is shown that even if lipophilic smectite is used as the dispersion stabilizer, the gel-like body fluid leakage preventing agent can be prepared to be 'other' in the water absorption test, and the time to form a solid gel is very fast 'as a body fluid' leakage prevention agent The dispersing stabilizer is a good substance. -42- 200913976 [Simplified description of the drawings] Fig. 1 is a schematic cross-sectional view showing the state of use of the conventional body treatment device. Fig. 2 is a view showing the body treatment device of the present invention. In one embodiment, (A) is a front view '(B) is a left side view, and (c) is a right side view. Fig. 3 is a longitudinal cross-sectional view along the center axis of the body treatment device shown in Fig. 2. Figure 4 is a cross-sectional view showing the central axis of the body treatment device shown in Figure 2. Figure 5 is a longitudinal sectional view showing the insertion tube of the body treatment device of the present invention. Figure 6 is a view showing the present invention. Other embodiments of the body processing apparatus are shown in the front view, (B) in the left side view, and (C) in the right side view. Fig. 7 shows the center axis of the body processing device shown in Fig. 6. Longitudinal view. Figure 8 shows A cross-sectional view along the central axis of the body treatment device shown in Fig. 6. Fig. 9 is a partial side elevational view showing another embodiment of the insertion tube of the body treatment device of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS FIG. 11 is a partial cross-sectional view showing another embodiment of the insertion tube of the body treatment device of the present invention. 43- 200913976 [Explanation of main component symbols] l,10,10a: injector 20,20a: cylindrical body 2 1,2 1 a : cylindrical material 22, 22a: discharge port part (spit portion) 2 3, 2 3 a : stop portion 24: protruding strip portion 2 5, 2 5 a : cover member 26: flange portion 27, 44: stop portion 28: tongue 29, 29a: protective cover 3 0 : Piston 3 1 : Piston rod 3 2 : Round flange portion 3 3 : Flange portion 34 : Rubber pad 3 5 : Disc-shaped portion 40 : Insertion tube 40 a : Insertion tube body 42 : Opening portion 43: Connection part 45: tongue 46: curved part -44 - 200913976 χ: body fluid leakage prevention agent Y: fibrous filling material A: nostril B: throat part C : Tongue D: Trachea E: Esophagus -45